Gary Kohanbash

Sever, R.E., Rosenblum, L.T., Stanley, K.C., Cortez, A.G., Menendez, D.M., Chagantipati, B., Nedrow, J.R., Edwards, W.B., Malek, M.M., & Kohanbash, G. (2025). Detection properties of indium-111 and IRDye800CW for intraoperative molecular imaging use across tissue phantom models. J Biomed Opt, 30(Suppl 1), S13705.SPIE, the international society for optics and photonics. doi: 10.1117/1.JBO.30.S1.S13705.

Azambuja, J.H., Yerneni, S.S., Maurer, L.M., Crentsil, H.E., Debom, G.N., Klei, L., Smyers, M., Sneiderman, C.T., Schwab, K.E., Acharya, R., Wu, Y.L., Ekambaram, P., Hu, D., Gough, P.J., Bertin, J., Melnick, A., Kohanbash, G., Bao, R., Lucas, P.C., & McAllister-Lucas, L.M. (2024). MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression. bioRxiv, 5(10-09), 2024.09.26.614808.Cold Spring Harbor Laboratory. doi: 10.1101/2024.09.26.614808.

Caisova, V., Rivero-Hinojosa, S., Tardito, S., Zhang, H., Lu, I.A., Chintala, N., Mochizuki, A., Pei, Y., Murad, N., Sneiderman, C., Kohanbash, G., Yang, J., & Rood, B. (2024). THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4 MEDULLOBLASTOMA. NEURO-ONCOLOGY, 26(Supplement_4), 0.Oxford University Press (OUP). doi: 10.1093/neuonc/noae064.494.

Cruz, A., Johnson, B., Gatesman, T., Halbert, M., Taori, S., Hu, B., Kohanbash, G., Pollack, I.F., & Agnihotri, S. (2024). The role of tumor microenvironment derived growth factors in pediatric brain tumors. CANCER RESEARCH, 84(7), lb307.American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2024-LB307.

Frederico, S.C., Raphael, I., Nisnboym, M., Huq, S., Schlegel, B.T., Sneiderman, C.T., Jackson, S.A., Jain, A., Olin, M.R., Rood, B.R., Pollack, I.F., Hwang, E.I., Rajasundaram, D., & Kohanbash, G. (2024). Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors. Expert Rev Clin Immunol, 20(11), 1411-1420.Taylor & Francis. doi: 10.1080/1744666X.2024.2390023.

Frederico, S.C., Sharma, N., Darling, C., Taori, S., Dubinsky, A.C., Zhang, X., Raphael, I., & Kohanbash, G. (2024). Myeloid cells as potential targets for immunotherapy in pediatric gliomas. Front Pediatr, 12, 1346493.Frontiers. doi: 10.3389/fped.2024.1346493.

Jha, R.M., Rajasundaram, D., Sneiderman, C., Schlegel, B.T., O'Brien, C., Xiong, Z., Janesko-Feldman, K., Trivedi, R., Vagni, V., Zusman, B.E., Catapano, J.S., Eberle, A., Desai, S.M., Jadhav, A.P., Mihaljevic, S., Miller, M., Raikwar, S., Rani, A., Rulney, J., Shahjouie, S., Raphael, I., Kumar, A., Phuah, C.L., Winkler, E.A., Simon, D.W., Kochanek, P.M., & Kohanbash, G. (2024). A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targets. Neuron, 112(18), 3069-3088.e4.Elsevier. doi: 10.1016/j.neuron.2024.06.021.

Nader, N.E., Frederico, S.C., Miller, T., Huq, S., Zhang, X., Kohanbash, G., & Hadjipanayis, C.G. (2024). Barriers to T Cell Functionality in the Glioblastoma Microenvironment. Cancers (Basel), 16(19), 3273.MDPI. doi: 10.3390/cancers16193273.

Pollack, I.F., Felker, J., Frederico, S.C., Raphael, I., & Kohanbash, G. (2024). Immunotherapy for pediatric low-grade gliomas. Childs Nerv Syst, 40(10), 3263-3275.Springer Nature. doi: 10.1007/s00381-024-06491-9.

Raphael, I., Mujeeb, A.A., Ampudia-Mesias, E., Sever, R.E., McClellan, B., Frederico, S.C., Sneiderman, C.T., Mirji, A., Daba, A., Puerta-Martinez, F., Nisnboym, M., Edwards, W.B., Graner, M., Moertel, C.L., Castro, M.G., Kohanbash, G., & Olin, M.R. (2024). CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection. bioRxiv, 5(09-23), 2024.09.08.611922.Cold Spring Harbor Laboratory. doi: 10.1101/2024.09.08.611922.

Song, S., Oft, H., Metwally, S., Paruchuri, S., Bielanin, J., Fiesler, V., Sneiderman, C., Kohanbash, G., & Sun, D. (2024). Deletion of Slc9a1 in Cx3cr1+ cells stimulated microglial subcluster CREB1 signaling and microglia-oligodendrocyte crosstalk. J Neuroinflammation, 21(1), 69.Springer Nature. doi: 10.1186/s12974-024-03065-z.

Vincze, S.R., Jaswal, A.P., Frederico, S.C., Nisnboym, M., Li, B., Xiong, Z., Sever, R.E., Sneiderman, C.T., Rodgers, M., Day, K.E., Latoche, J.D., Foley, L.M., Hitchens, T.K., Frederick, R., Patel, R.B., Hadjipanayis, C.G., Raphael, I., Nedrow, J.R., Edwards, W.B., & Kohanbash, G. (2024). ImmunoPET imaging of TIGIT in the glioma microenvironment. Sci Rep, 14(1), 5305.Springer Nature. doi: 10.1038/s41598-024-55296-y.

Xiong, Z., Raphael, I., Olin, M., Okada, H., Li, X., & Kohanbash, G. (2024). Glioblastoma vaccines: past, present, and opportunities. EBioMedicine, 100, 104963.Elsevier. doi: 10.1016/j.ebiom.2023.104963.

Azambuja, J.H., Yerneni, S.S., Debom, G.N., Maurer, L.M., Butterfield, H.E., Klei, L.R., Kohanbash, G., Lucas, P.C., & McAllister-Lucas, L.M. (2023). Dual benefit of MALT1 blockade in glioblastoma. CANCER RESEARCH, 83(7), 4442.American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2023-4442.

Bou-Samra, P., Muhammad, N., Chang, A., Karsalia, R., Azari, F., Kennedy, G., Stummer, W., Tanyi, J., Martin, L., Vahrmeijer, A., Smith, B., Rosenthal, E., Wagner, P., Rice, D., Lee, A., Abdelhafeez, A., Malek, M.M., Kohanbash, G., Barry Edwards, W., Henderson, E., Skjøth-Rasmussen, J., Orosco, R., Gibbs, S., Farnam, R.W., Shankar, L., Sumer, B., Kumar, A.T.N., Marcu, L., Li, L., Greuv, V., Delikatny, E.J., Lee, J.Y.K., & Singhal, S. (2023). Intraoperative molecular imaging: 3rd biennial clinical trials update. J Biomed Opt, 28(5), 050901.SPIE, the international society for optics and photonics. doi: 10.1117/1.JBO.28.5.050901.

Chen, A., Chao, Y., Zou, H., McCarl, L.H., Kohanbash, G., & Hu, B. (2023). Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models. STAR Protoc, 4(1), 102049.Elsevier. doi: 10.1016/j.xpro.2023.102049.

Frederico, S.C., Darling, C., Bielanin, J.P., Dubinsky, A.C., Zhang, X., Hadjipanayis, C.G., & Kohanbash, G. (2023). Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier. Front Immunol, 14, 1057567.Frontiers. doi: 10.3389/fimmu.2023.1057567.

Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R.L., Komohara, Y., Decker, S.A., Ohlfest, J.R., & Okada, H. (2023). Supplementary Figure 1 from COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells. doi: 10.1158/0008-5472.22390349.

Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R.L., Komohara, Y., Decker, S.A., Ohlfest, J.R., & Okada, H. (2023). Data from COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells. doi: 10.1158/0008-5472.c.6502916.

Fujita, M., Scheurer, M.E., Decker, S.A., McDonald, H.A., Kohanbash, G., Kastenhuber, E.R., Kato, H., Bondy, M.L., Ohlfest, J.R., & Okada, H. (2023). Supplementary Data from Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans. doi: 10.1158/1078-0432.22441308.

Fujita, M., Zhu, X., Ueda, R., Sasaki, K., Kohanbash, G., Kastenhuber, E.R., McDonald, H.A., Gibson, G.A., Watkins, S.C., Muthuswamy, R., Kalinski, P., & Okada, H. (2023). Supplementary Figure 2 from Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10. doi: 10.1158/0008-5472.22381533.

Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A.H., Amankulor, N., Fujita, M., Ohlfest, J.R., & Okada, H. (2023). Supplementary Figure 5 from GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α. doi: 10.1158/0008-5472.22396539.v1.

Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A.H., Amankulor, N., Fujita, M., Ohlfest, J.R., & Okada, H. (2023). Supplementary Figure 5 from GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α. doi: 10.1158/0008-5472.22396539.

Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A.H., Amankulor, N., Fujita, M., Ohlfest, J.R., & Okada, H. (2023). Data from GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α. doi: 10.1158/0008-5472.c.6504603.

Luo, L., Guan, X., Begum, G., Ding, D., Gayden, J., Hasan, M.N., Fiesler, V.M., Dodelson, J., Kohanbash, G., Hu, B., Amankulor, N.M., Jia, W., Castro, M.G., Sun, B., & Sun, D. (2023). Figure S7 from Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis. doi: 10.1158/1535-7163.22521367.

Luo, L., Guan, X., Begum, G., Ding, D., Gayden, J., Hasan, M.N., Fiesler, V.M., Dodelson, J., Kohanbash, G., Hu, B., Amankulor, N.M., Jia, W., Castro, M.G., Sun, B., & Sun, D. (2023). Figure S7 from Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis. doi: 10.1158/1535-7163.22521367.v1.

Nisnboym, M., Vincze, S.R., Xiong, Z., Sneiderman, C.T., Raphael, R.A., Li, B., Jaswal, A.P., Sever, R.E., Day, K.E., LaToche, J.D., Foley, L.M., Karimi, H., Hitchens, T.K., Agnihotri, S., Hu, B., Rajasundaram, D., Anderson, C.J., Blumenthal, D.T., Pearce, T.M., Uttam, S., Nedrow, J.R., Panigrahy, A., Pollack, I.F., Lieberman, F.S., Drappatz, J., Raphael, I., Edwards, W.B., & Kohanbash, G. (2023). Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma. Cancer Res Commun, 3(7), 1173-1188.American Association for Cancer Research (AACR). doi: 10.1158/2767-9764.CRC-22-0434.

Nisnboym, M., Vincze, S.R., Xiong, Z., Sneiderman, C.T., Raphael, R.A., Li, B., Jaswal, A.P., Sever, R.E., Day, K.E., LaToche, J.D., Foley, L.M., Karimi, H., Hitchens, T.K., Agnihotri, S., Hu, B., Rajasundaram, D., Anderson, C.J., Blumenthal, D.T., Pearce, T.M., Uttam, S., Nedrow, J.R., Panigrahy, A., Pollack, I.F., Lieberman, F.S., Drappatz, J., Raphael, I., Edwards, W.B., & Kohanbash, G. (2023). Supplementary Figure 3 from Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma. doi: 10.1158/2767-9764.23635574.v1.

Nisnboym, M., Vincze, S.R., Xiong, Z., Sneiderman, C.T., Raphael, R.A., Li, B., Jaswal, A.P., Sever, R.E., Day, K.E., LaToche, J.D., Foley, L.M., Karimi, H., Hitchens, T.K., Agnihotri, S., Hu, B., Rajasundaram, D., Anderson, C.J., Blumenthal, D.T., Pearce, T.M., Uttam, S., Nedrow, J.R., Panigrahy, A., Pollack, I.F., Lieberman, F.S., Drappatz, J., Raphael, I., Edwards, W.B., & Kohanbash, G. (2023). Supplementary Figure 5 from Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma. doi: 10.1158/2767-9764.23635568.v1.

Nisnboym, M., Vincze, S.R., Xiong, Z., Sneiderman, C.T., Raphael, R.A., Li, B., Sever, R.E., Jaswal, A.P., Day, K.E., Latoche, J.D., Foley, L.M., Karimi, H., Hitchens, T.K., Agnihotri, S., Hu, B., Rajasundaram, D., Anderson, C.J., Blumenthal, D.T., Pearce, T.M., Uttam, S., Nedrow, J.R., Panigrahy, A., Pollack, I.F., Lieberman, F.S., Drappatz, J., Raphael, I., Edwards, W.B., & Kohanbash, G. (2023). Data from Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival following Immunotherapy in Murine GBM. doi: 10.1158/2767-9764.c.6689057.v1.

Okada, H., Butterfield, L.H., Hamilton, R.L., Hoji, A., Sakaki, M., Ahn, B.J., Kohanbash, G., Drappatz, J., Engh, J., Amankulor, N., Lively, M.O., Chan, M.D., Salazar, A.M., Shaw, E.G., Potter, D.M., & Lieberman, F.S. (2023). Supplementary Figure 2 from Induction of Robust Type-I CD8⁺ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC. doi: 10.1158/1078-0432.22461575.

Raphael, I., Nisnboym, M., Sneiderman, C., Xiong, Z., Pollack, I., Chikina, M., Rajasundaram, D., & Kohanbash, G. (2023). IMMU-51. THE LANDSCAPE OF TUMOR INFILTRATING T CELLS (TILS) OF CHILDHOOD BRAIN TUMORS. Neuro-Oncology, 25(Supplement_5), v154.Oxford University Press (OUP). doi: 10.1093/neuonc/noad179.0583.

Sever, R., Rosenblum, L.T., Schmidt, L., Hartwick, S., Schwab, K., Wu, Y., Raphael, I., Reyes, M., Edwards, W.B., Malek, M., & Kohanbash, G. (2023). Novel orthotopic model of neuroblastoma in RNU homozygous rats. 2023.01.16.523967.Cold Spring Harbor Laboratory. doi: 10.1101/2023.01.16.523967.

Sever, R.E., Rosenblum, L.T., Reyes-Múgica, M., Edwards, W.B., Malek, M.M., & Kohanbash, G. (2023). Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model. Sci Rep, 13(1), 20214.Springer Nature. doi: 10.1038/s41598-023-47537-3.

Song, S., Oft, H., Metwally, S., Paruchuri, S., Bielanin, J., Fiesler, V., Sneiderman, C., Kohanbash, G., & Sun, D. (2023). Deletion of Slc9a1 in Cx3cr1+ cells stimulated microglial subcluster CREB1-BDNF signaling and microglia-oligodendrocyte crosstalk. Research Square Platform. doi: 10.21203/rs.3.rs-3710892/v1.

Steffke, E.E., McAuliffe, J., Almeida, V.P., Wicki, A., Noblecourt, L., Kohanbash, G., Okada, H., Leung, C.S.K., Terabe, M., & Van den Eynde, B.J. (2023). Heterologous primeboost viral vector vaccines for the treatment of a P1A-expressing BGL1 glioblastoma model. CANCER RESEARCH, 83(7), 682.American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2023-682.

Steffke, E.E., Noblecourt, L., Almeida, V.P., Wicki, A., McAuliffe, J., Kohanbash, G., Okada, H., Leung, C., Terabe, M., & Van den Eynde, B. (2023). Heterologous prime-boost viral vector cancer vaccines have protective effects against a syngeneic mouse model of glioblastoma. JOURNAL OF IMMUNOLOGY, 210(1), 145.12.The American Association of Immunologists. doi: 10.4049/jimmunol.210.Supp.145.12.

Wang, L., Babikir, H., Müller, S., Yagnik, G., Shamardani, K., Catalan, F., Kohanbash, G., Alvarado, B., Di Lullo, E., Kriegstein, A., Shah, S., Wadhwa, H., Chang, S.M., Phillips, J.J., Aghi, M.K., & Diaz, A.A. (2023). Table S5 from The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation. doi: 10.1158/2159-8290.22536238.v1.

Wang, L., Babikir, H., Müller, S., Yagnik, G., Shamardani, K., Catalan, F., Kohanbash, G., Alvarado, B., Di Lullo, E., Kriegstein, A., Shah, S., Wadhwa, H., Chang, S.M., Phillips, J.J., Aghi, M.K., & Diaz, A.A. (2023). Table S1 from The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation. doi: 10.1158/2159-8290.22536250.

Zou, H., Poore, B., Brown, E.E., Qian, J., Xie, B., Asimakidou, E., Razskazovskiy, V., Ayrapetian, D., Sharma, V., Xia, S., Liu, F., Chen, A., Guan, Y., Li, Z., Wanggou, S., Saulnier, O., Ly, M., Fellows-Mayle, W., Xi, G., Tomita, T., Resnick, A.C., Mack, S.C., Raabe, E.H., Eberhart, C.G., Sun, D., Stronach, B.E., Agnihotri, S., Kohanbash, G., Lu, S., Herrup, K., Rich, J.N., Gittes, G.K., Broniscer, A., Hu, Z., Li, X., Pollack, I.F., Friedlander, R.M., Hainer, S.J., Taylor, M.D., & Hu, B. (2023). A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis. Nat Cell Biol, 25(3), 493-507.Springer Nature. doi: 10.1038/s41556-023-01093-0.

Bhatia, A., Lee, V.K., Qian, Y., Paladino, M., Ceschin, R., Hect, J., Mountz, J.M., Sun, D., Kohanbash, G., Pollack, I.F., Jakacki, R.I., Boada, F., & Panigrahy, A. (2022). Quantitative Sodium (23Na) MRI in Pediatric Gliomas: Initial Experience. doi: 10.21203/rs.3.rs-1385814/v1.

Bhatia, A., Lee, V.K., Qian, Y., Paldino, M.J., Ceschin, R., Hect, J., Mountz, J.M., Sun, D., Kohanbash, G., Pollack, I.F., Jakacki, R.I., Boada, F., & Panigrahy, A. (2022). Quantitative Sodium (23Na) MRI in Pediatric Gliomas: Initial Experience. Diagnostics (Basel), 12(5), 1223.MDPI. doi: 10.3390/diagnostics12051223.

Chuntova, P., Hou, Y., Naka, R., Yamamichi, A., Chen, T., Goretsky, Y., Hatae, R., Nejo, T., Kohanbash, G., Mende, A.L., Montoya, M., Downey, K.M., Diebold, D., Skinner, J., Liang, H.E., Schwer, B., & Okada, H. (2022). Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. Neuro Oncol, 24(2), 259-272.Oxford University Press (OUP). doi: 10.1093/neuonc/noab182.

Frederico, S.C., Zhang, X., Hu, B., & Kohanbash, G. (2022). Pre-clinical models for evaluating glioma targeted immunotherapies. Front Immunol, 13, 1092399.Frontiers. doi: 10.3389/fimmu.2022.1092399.

Golbourn, B.J., Halbert, M.E., Halligan, K., Varadharajan, S., Krug, B., Mbah, N.E., Kabir, N., Stanton, A.C.J., Locke, A.L., Casillo, S.M., Zhao, Y., Sanders, L.M., Cheney, A., Mullett, S.J., Chen, A., Wassell, M., Andren, A., Perez, J., Jane, E.P., Premkumar, D.R.D., Koncar, R.F., Mirhadi, S., McCarl, L.H., Chang, Y.F., Wu, Y.L., Gatesman, T.A., Cruz, A.F., Zapotocky, M., Hu, B., Kohanbash, G., Wang, X., Vartanian, A., Moran, M.F., Lieberman, F., Amankulor, N.M., Wendell, S.G., Vaske, O.M., Panigrahy, A., Felker, J., Bertrand, K.C., Kleinman, C.L., Rich, J.N., Friedlander, R.M., Broniscer, A., Lyssiotis, C., Jabado, N., Pollack, I.F., Mack, S.C., & Agnihotri, S. (2022). Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome. Nat Cancer, 3(5), 629-648.Springer Nature. doi: 10.1038/s43018-022-00348-3.

Golbourn, B.J., Halbert, M.E., Halligan, K., Varadharajan, S., Krug, B., Mbah, N.E., Kabir, N., Stanton, A.C.J., Locke, A.L., Casillo, S.M., Zhao, Y., Sanders, L.M., Cheney, A., Mullett, S.J., Chen, A., Wassell, M., Andren, A., Perez, J., Jane, E.P., Premkumar, D.R.D., Koncar, R.F., Mirhadi, S., McCarl, L.H., Chang, Y.F., Wu, Y.L., Gatesman, T.A., Cruz, A.F., Zapotocky, M., Hu, B., Kohanbash, G., Wang, X., Vartanian, A., Moran, M.F., Lieberman, F., Amankulor, N.M., Wendell, S.G., Vaske, O.M., Panigrahy, A., Felker, J., Bertrand, K.C., Kleinman, C.L., Rich, J.N., Friedlander, R.M., Broniscer, A., Lyssiotis, C., Jabado, N., Pollack, I.F., Mack, S.C., & Agnihotri, S. (2022). Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome. Nat Cancer, 3(7), 899.Springer Nature. doi: 10.1038/s43018-022-00407-9.

Panigrahy, A., Jakacki, R.I., Pollack, I.F., Ceschin, R., Okada, H., Nelson, M.D., Kohanbash, G., Dhall, G., & Bluml, S. (2022). Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines. Cancers (Basel), 14(23), 5995.MDPI. doi: 10.3390/cancers14235995.

Rinehardt, H.N., Longo, S., Gilbert, R., Shoaf, J.N., Edwards, W.B., Kohanbash, G., & Malek, M.M. (2022). Handheld PET Probe for Pediatric Cancer Surgery. Cancers (Basel), 14(9), 2221.MDPI. doi: 10.3390/cancers14092221.

Chen, A., Jiang, Y., Li, Z., Wu, L., Santiago, U., Zou, H., Cai, C., Sharma, V., Guan, Y., McCarl, L.H., Ma, J., Wu, Y.L., Michel, J., Shi, Y., Konnikova, L., Amankulor, N.M., Zinn, P.O., Kohanbash, G., Agnihotri, S., Lu, S., Lu, X., Sun, D., Gittes, G.K., Wang, Q., Xiao, X., Yimlamai, D., Pollack, I.F., Camacho, C.J., & Hu, B. (2021). Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma. J Clin Invest, 131(16), 147552.American Society for Clinical Investigation. doi: 10.1172/JCI147552.

Chuntova, P., Hou, Y., Naka, R., Goretsky, Y., Nejo, T., Kohanbash, G., Chen, T., Mende, A.L., Montoya, M., Yamamichi, A., Downey, K.M., Diebold, D., Skinner, J., Liang, H.E., Schwer, B., & Okada, H. (2021). Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. 2021.01.31.429020.Cold Spring Harbor Laboratory. doi: 10.1101/2021.01.31.429020.

Foster, A., Nigam, S., Tatum, D.S., Raphael, I., Xu, J., Kumar, R., Plakseychuk, E., Latoche, J.D., Vincze, S., Li, B., Giri, R., McCarl, L.H., Edinger, R., Ak, M., Peddagangireddy, V., Foley, L.M., Hitchens, T.K., Colen, R.R., Pollack, I.F., Panigrahy, A., Magda, D., Anderson, C.J., Edwards, W.B., & Kohanbash, G. (2021). Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma. EBioMedicine, 71, 103571.Elsevier. doi: 10.1016/j.ebiom.2021.103571.

Glorioso, J.C., Cohen, J.B., Goins, W.F., Hall, B., Jackson, J.W., Kohanbash, G., Amankulor, N., Kaur, B., Caligiuri, M.A., Chiocca, E.A., Holland, E.C., & Quéva, C. (2021). Oncolytic HSV Vectors and Anti-Tumor Immunity. Curr Issues Mol Biol, 41, 381-468.MDPI. doi: 10.21775/cimb.041.381.

Hasan, M.N., Luo, L., Ding, D., Song, S., Bhuiyan, M.I.H., Liu, R., Foley, L.M., Guan, X., Kohanbash, G., Hitchens, T.K., Castro, M.G., Zhang, Z., & Sun, D. (2021). Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells. Theranostics, 11(3), 1295-1309.Ivyspring International Publisher. doi: 10.7150/thno.50150.

Jackson, J.W., Hall, B.L., Marzulli, M., Shah, V.K., Bailey, L., Chiocca, E.A., Goins, W.F., Kohanbash, G., Cohen, J.B., & Glorioso, J.C. (2021). Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment. Mol Ther Oncolytics, 22, 444-453.Elsevier. doi: 10.1016/j.omto.2021.07.009.

Raphael, I., Kumar, R., McCarl, L.H., Shoger, K., Wang, L., Sandlesh, P., Sneiderman, C.T., Allen, J., Zhai, S., Campagna, M.L., Foster, A., Bruno, T.C., Agnihotri, S., Hu, B., Castro, B.A., Lieberman, F.S., Broniscer, A., Diaz, A.A., Amankulor, N.M., Rajasundaram, D., Pollack, I.F., & Kohanbash, G. (2021). TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma. Front Immunol, 12, 637146.Frontiers. doi: 10.3389/fimmu.2021.637146.

Babikir, H., Wang, L., Shamardani, K., Catalan, F., Kohanbash, G., Aghi, M.K., Phillips, J.J., & Diaz, A.A. (2020). Optimizing precision combination therapies based on single-cell profiling of brain tumor biopsies. CANCER RESEARCH, 80(16), 6346.American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2020-6346.

Glorioso, J.C., Cohen, J.B., Goins, W.F., Hall, B., Jackson, J.W., Kohanbash, G., Amankulor, N., Kaur, B., Caligiuri, M.A., Chiocca, E.A., Holland, E.C., & Quéva, C. (2020). Oncolytic HSV Vectors and Anti-Tumor Immunity. In Alphaherpesviruses: Molecular Biology, Host Interactions and Control. Caister Academic Press. doi: 10.21775/9781913652555.11.

Luo, L., Guan, X., Begum, G., Ding, D., Gayden, J., Hasan, M.N., Fiesler, V.M., Dodelson, J., Kohanbash, G., Hu, B., Amankulor, N.M., Jia, W., Castro, M.G., Sun, B., & Sun, D. (2020). Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis. Mol Cancer Ther, 19(7), 1550-1561.American Association for Cancer Research (AACR). doi: 10.1158/1535-7163.MCT-19-0910.

Nigam, S., McCarl, L., Kumar, R., Edinger, R.S., Kurland, B.F., Anderson, C.J., Panigrahy, A., Kohanbash, G., & Edwards, W.B. (2020). Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody. Mol Imaging Biol, 22(3), 685-694.Springer Nature. doi: 10.1007/s11307-019-01427-1.

Brown, P., RELISH Consortium, & Zhou, Y. (2019). Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database (Oxford), 2019, baz085.Oxford University Press (OUP). doi: 10.1093/database/baz085.

Koncar, R.F., Dey, B.R., Stanton, A.C.J., Agrawal, N., Wassell, M.L., McCarl, L.H., Locke, A.L., Sanders, L., Morozova-Vaske, O., Myers, M.I., Hamilton, R.L., Carcaboso, A.M., Kohanbash, G., Hu, B., Amankulor, N.M., Felker, J., Kambhampati, M., Nazarian, J., Becher, O.J., James, C.D., Hashizume, R., Broniscer, A., Pollack, I.F., & Agnihotri, S. (2019). Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas. Cancer Res, 79(16), 4026-4041.American Association for Cancer Research (AACR). doi: 10.1158/0008-5472.CAN-18-3521.

Nigam, S., McCarl, L., Kumar, R., Anderson, C., Edwards, B., & Kohanbash, G. (2019). TMIC-39. DEVELOPMENT OF CD11b TRACER FOR THE IMMUNE PET IMAGING IN GLIOBLASTOMA MODEL - COULD BE A GAME CHANGER FOR IMMUNOTHERAPY APPROACHES. Neuro-Oncology, 21(Supplement_6), vi256.Oxford University Press (OUP). doi: 10.1093/neuonc/noz175.1073.

Nigam, S., McCarl, L., Kumar, R., Edinger, R.S., Kurland, B.F., Anderson, C.J., Panigrahy, A., Kohanbash, G., & Edwards, W.B. (2019). Preclinical immunoPET imaging of glioblastoma-infiltrating myeloid cells using Zirconium-89-labeled anti-CD11b antibody. 614511.Cold Spring Harbor Laboratory. doi: 10.1101/614511.

Wang, L., Babikir, H., Müller, S., Yagnik, G., Shamardani, K., Catalan, F., Kohanbash, G., Alvarado, B., Di Lullo, E., Kriegstein, A., Shah, S., Wadhwa, H., Chang, S.M., Phillips, J.J., Aghi, M.K., & Diaz, A.A. (2019). The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation. Cancer Discov, 9(12), 1708-1719.American Association for Cancer Research (AACR). doi: 10.1158/2159-8290.CD-19-0329.

Chheda, Z.S., Kohanbash, G., Okada, K., Jahan, N., Sidney, J., Pecoraro, M., Yang, X., Carrera, D.A., Downey, K.M., Shrivastav, S., Liu, S., Lin, Y., Lagisetti, C., Chuntova, P., Watchmaker, P.B., Mueller, S., Pollack, I.F., Rajalingam, R., Carcaboso, A.M., Mann, M., Sette, A., Garcia, K.C., Hou, Y., & Okada, H. (2018). Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med, 215(1), 141-157.Rockefeller University Press. doi: 10.1084/jem.20171046.

Guan, X., Hasan, M.N., Begum, G., Kohanbash, G., Carney, K.E., Pigott, V.M., Persson, A.I., Castro, M.G., Jia, W., & Sun, D. (2018). Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy. Cell Death Dis, 9(10), 1010.Springer Nature. doi: 10.1038/s41419-018-1062-3.

Guan, X., Luo, L., Begum, G., Kohanbash, G., Song, Q., Rao, A., Amankulor, N., Sun, B., Sun, D., & Jia, W. (2018). Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas. J Exp Clin Cancer Res, 37(1), 255.Springer Nature. doi: 10.1186/s13046-018-0923-z.

Müller, S., Agnihotri, S., Shoger, K.E., Myers, M.I., Smith, N., Chaparala, S., Villanueva, C.R., Chattopadhyay, A., Lee, A.V., Butterfield, L.H., Diaz, A., Okada, H., Pollack, I.F., & Kohanbash, G. (2018). Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomas. JCI Insight, 3(7), 104.American Society for Clinical Investigation. doi: 10.1172/jci.insight.98791.

Müller, S., Di Lullo, E., Bhaduri, A., Alvarado, B., Yagnik, G., Kohanbash, G., Aghi, M., & Diaz, A. (2018). A single-cell atlas of human glioblastoma reveals a single axis of phenotype in tumor-propagating cells. 377606.Cold Spring Harbor Laboratory. doi: 10.1101/377606.

Shoger, K., McCarl, L., Gilbert, R., Villanueva, C., Levy, N., Amankulor, N., Pollack, I., & Kohanbash, G. (2018). IMMU-18. TARGETING THE PD1 AND TIGIT CHECKPOINT PATHWAYS FOR ADULT AND PEDIATRIC GLIOMAS. Neuro-Oncology, 20(suppl_6), vi125.Oxford University Press (OUP). doi: 10.1093/neuonc/noy148.521.

Castro, B.A., Flanigan, P., Jahangiri, A., Hoffman, D., Chen, W., Kuang, R., De Lay, M., Yagnik, G., Wagner, J.R., Mascharak, S., Sidorov, M., Shrivastav, S., Kohanbash, G., Okada, H., & Aghi, M.K. (2017). Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy. Oncogene, 36(26), 3749-3759.Springer Nature. doi: 10.1038/onc.2017.1.

Chheda, Z., Kohanbash, G., Sidney, J., Okada, K., Jahan, N., Carrera, D., Watchmaker, P., Downey, K., Liu, S., Shrivastav, S., Mueller, S., Pollack, I.F., Carcaboso, A.M., Sette, A., Hou, Y., & Okada, H. (2017). Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma. CANCER RESEARCH, 77(13_Supplement), 3767.American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2017-3767.

Kohanbash, G., Carrera, D.A., Shrivastav, S., Ahn, B.J., Jahan, N., Mazor, T., Chheda, Z.S., Downey, K.M., Watchmaker, P.B., Beppler, C., Warta, R., Amankulor, N.A., Herold-Mende, C., Costello, J.F., & Okada, H. (2017). Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. J Clin Invest, 127(4), 1425-1437.American Society for Clinical Investigation. doi: 10.1172/JCI90644.

Müller, S., Kohanbash, G., Liu, S.J., Alvarado, B., Carrera, D., Bhaduri, A., Watchmaker, P.B., Yagnik, G., Di Lullo, E., Malatesta, M., Amankulor, N.M., Kriegstein, A.R., Lim, D.A., Aghi, M., Okada, H., & Diaz, A. (2017). Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol, 18(1), 234.Springer Nature. doi: 10.1186/s13059-017-1362-4.

Ager, C., Reilley, M., Nicholas, C., Bartkowiak, T., Jaiswal, A., Curran, M., Albershardt, T.C., Bajaj, A., Archer, J.F., Reeves, R.S., Ngo, L.Y., Berglund, P., ter Meulen, J., Denis, C., Ghadially, H., Arnoux, T., Chanuc, F., Fuseri, N., Wilkinson, R.W., Wagtmann, N., Morel, Y., Andre, P., Atkins, M.B., Carlino, M.S., Ribas, A., Thompson, J.A., Choueiri, T.K., Hodi, F.S., Hwu, W.J., McDermott, D.F., Atkinson, V., Cebon, J.S., Fitzharris, B., Jameson, M.B., McNeil, C., Hill, A.G., Mangin, E., Ahamadi, M., van Vugt, M., van Zutphen, M., Ibrahim, N., Long, G.V., Gartrell, R., Blake, Z., Simoes, I., Fu, Y., Saito, T., Qian, Y., Lu, Y., Saenger, Y.M., Budhu, S., De Henau, O., Zappasodi, R., Schlunegger, K., Freimark, B., Hutchins, J., Barker, C.A., Wolchok, J.D., Merghoub, T., Burova, E., Allbritton, O., Hong, P., Dai, J., Pei, J., Liu, M., Kantrowitz, J., Lai, V., Poueymirou, W., MacDonald, D., Ioffe, E., Mohrs, M., Olson, W., Thurston, G., Capasso, C., Frascaro, F., Carpi, S., Tähtinen, S., Feola, S., Fusciello, M., Peltonen, K., Martins, B., Sjöberg, M., Pesonen, S., Ranki, T., Kyruk, L., Ylösmäki, E., Cerullo, V., Cerignoli, F., Xi, B., Guenther, G., Yu, N., Muir, L., Zhao, L., Abassi, Y., Cervera-Carrascón, V., Siurala, M., Santos, J., Havunen, R., Parviainen, S., Hemminki, A., Dalgleish, A., Mudan, S., DeBenedette, M., Plachco, A., Gamble, A., Grogan, E.W., Krisko, J., Tcherepanova, I., Nicolette, C., Dhupkar, P., Yu, L., Kleinerman, E.S., Gordon, N., Grenga, I., Lepone, L., Gameiro, S., Knudson, K.M., Fantini, M., Tsang, K., Hodge, J., Donahue, R., Schlom, J., Evans, E., Bussler, H., Mallow, C., Reilly, C., Torno, S., Scrivens, M., Foster, C., Howell, A., Balch, L., Knapp, A., Leonard, J.E., Paris, M., Fisher, T., Hu-Lieskovan, S., Ribas, A., Smith, E., Zauderer, M., Fogler, W., Franklin, M., Thayer, M., Saims, D., Magnani, J.L., Gong, J., Gray, M., Hutchins, J., Freimark, B., Fromm, G., de Silva, S., Giffin, L., Xu, X., Rose, J., Schreiber, T.H., Fantini, M., Gameiro, S.R., Knudson, K.M., Clavijo, P.E., Allen, C.T., Donahue, R., Lepone, L., Grenga, I., Hodge, J.W., Tsang, K.Y., Schlom, J., Gray, M., Gong, J., Hutchins, J., Freimark, B., Grogan, J., Manieri, N., Chiang, E., Caplazi, P., Yadav, M., Hagner, P., Chiu, H., Waldman, M., Klippel, A., Thakurta, A., Pourdehnad, M., Gandhi, A., Henrich, I., Quick, L., Young, R., Chou, M., Hotson, A., Willingham, S., Ho, P., Choy, C., Laport, G., McCaffery, I., Miller, R., Tipton, K.A., Wong, K.R., Singson, V., Wong, C., Chan, C., Huang, Y., Liu, S., Richardson, J.H., Kavanaugh, W.M., West, J., Irving, B.A., Tipton, K.A., Wong, K.R., Singson, V., Wong, C., Chan, C., Huang, Y., Liu, S., Richardson, J.H., Kavanaugh, W.M., West, J., Irving, B.A., Jaini, R., Loya, M., Eng, C., Johnson, M.L., Adjei, A.A., Opyrchal, M., Ramalingam, S., Janne, P.A., Dominguez, G., Gabrilovich, D., de Leon, L., Hasapidis, J., Diede, S.J., Ordentlich, P., Cruickshank, S., Meyers, M.L., Hellmann, M.D., Kalinski, P., Zureikat, A., Edwards, R., Muthuswamy, R., Obermajer, N., Urban, J., Butterfield, L.H., Gooding, W., Zeh, H., Bartlett, D., Zubkova, O., Agapova, L., Kapralova, M., Krasovskaia, L., Ovsepyan, A., Lykov, M., Eremeev, A., Bokovanov, V., Grigoryeva, O., Karpov, A., Ruchko, S., Nicolette, C., Shuster, A., Khalil, D.N., Campesato, L.F., Li, Y., Merghoub, T., Wolchok, J.D., Lazorchak, A.S., Patterson, T.D., Ding, Y., Sasikumar, P., Sudarshan, N., Gowda, N., Ramachandra, R., Samiulla, D., Giri, S., Eswarappa, R., Ramachandra, M., Tuck, D., Wyant, T., Leshem, J., Liu, X.F., Bera, T., Terabe, M., Bossenmaier, B., Niederfellner, G., Reiter, Y., Pastan, I., Xia, L., Xia, Y., Hu, Y., Wang, Y., Bao, Y., Dai, F., Huang, S., Hurt, E., Hollingsworth, R.E., Lum, L.G., Chang, A.E., Wicha, M.S., Li, Q., Mace, T., Makhijani, N., Talbert, E., Young, G., Guttridge, D., Conwell, D., Lesinski, G.B., Gonzales, R.J.M., Huffman, A.P., Wang, X.K., Reshef, R., MacKinnon, A., Chen, J., Gross, M., Marguier, G., Shwonek, P., Sotirovska, N., Steggerda, S., Parlati, F., Makkouk, A., Bennett, M.K., Chen, J., Emberley, E., Gross, M., Huang, T., Li, W., MacKinnon, A., Marguier, G., Neou, S., Pan, A., Zhang, J., Zhang, W., Parlati, F., Marshall, N., Marron, T.U., Agudo, J., Brown, B., Brody, J., McQuinn, C., Mace, T., Farren, M., Komar, H., Shakya, R., Young, G., Ludwug, T., Lesinski, G.B., Morillon, Y.M., Hammond, S.A., Schlom, J., Greiner, J.W., Nath, P.R., Schwartz, A.L., Maric, D., Roberts, D.D., Obermajer, N., Bartlett, D., Kalinski, P., Naing, A., Papadopoulos, K.P., Autio, K.A., Wong, D.J., Patel, M., Falchook, G., Pant, S., Ott, P.A., Whiteside, M., Patnaik, A., Mumm, J., Janku, F., Chan, I., Bauer, T., Colen, R., VanVlasselaer, P., Brown, G.L., Tannir, N.M., Oft, M., Infante, J., Lipson, E., Gopal, A., Neelapu, S.S., Armand, P., Spurgeon, S., Leonard, J.P., Hodi, F.S., Sanborn, R.E., Melero, I., Gajewski, T.F., Maurer, M., Perna, S., Gutierrez, A.A., Clynes, R., Mitra, P., Suryawanshi, S., Gladstone, D., Callahan, M.K., Crooks, J., Brown, S., Gauthier, A., de Boisferon, M.H., MacDonald, A., Brunet, L.R., Rothwell, W.T., Bell, P., Wilson, J.M., Sato-Kaneko, F., Yao, S., Zhang, S.S., Carson, D.A., Guiducci, C., Coffman, R.L., Kitaura, K., Matsutani, T., Suzuki, R., Hayashi, T., Cohen, E.E.W., Schaer, D., Li, Y., Dobkin, J., Amatulli, M., Hall, G., Doman, T., Manro, J., Dorsey, F.C., Sams, L., Holmgaard, R., Persaud, K., Ludwig, D., Surguladze, D., Kauh, J.S., Novosiadly, R., Kalos, M., Driscoll, K., Pandha, H., Ralph, C., Harrington, K., Curti, B., Sanborn, R.E., Akerley, W., Gupta, S., Melcher, A., Mansfield, D., Kaufman, D.R., Schmidt, E., Grose, M., Davies, B., Karpathy, R., Shafren, D., Shamalov, K., Cohen, C., Sharma, N., Allison, J., Shekarian, T., Valsesia-Wittmann, S., Caux, C., Marabelle, A., Slomovitz, B.M., Moore, K.M., Youssoufian, H., Posner, M., Tewary, P., Brooks, A.D., Xu, Y.M., Wijeratne, K., Gunatilaka, L.A.A., Sayers, T.J., Vasilakos, J.P., Alston, T., Dovedi, S., Elvecrog, J., Grigsby, I., Herbst, R., Johnson, K., Moeckly, C., Mullins, S., Siebenaler, K., SternJohn, J., Tilahun, A., Tomai, M.A., Vogel, K., Wilkinson, R.W., Vietsch, E.E., Wellstein, A., Wythes, M., Crosignani, S., Tumang, J., Alekar, S., Bingham, P., Cauwenberghs, S., Chaplin, J., Dalvie, D., Denies, S., De Maeseneire, C., Feng, J., Frederix, K., Greasley, S., Guo, J., Hardwick, J., Kaiser, S., Jessen, K., Kindt, E., Letellier, M.C., Li, W., Maegley, K., Marillier, R., Miller, N., Murray, B., Pirson, R., Preillon, J., Rabolli, V., Ray, C., Ryan, K., Scales, S., Srirangam, J., Solowiej, J., Stewart, A., Streiner, N., Torti, V., Tsaparikos, K., Zheng, X., Driessens, G., Gomes, B., Kraus, M., Xu, C., Zhang, Y., Kradjian, G., Qin, G., Qi, J., Xu, X., Marelli, B., Yu, H., Guzman, W., Tighe, R., Salazar, R., Lo, K.M., English, J., Radvanyi, L., Lan, Y., Zappasodi, R., Budhu, S., Hellmann, M.D., Postow, M., Senbabaoglu, Y., Gasmi, B., Zhong, H., Li, Y., Liu, C., Hirschhorhn-Cymerman, D., Wolchok, J.D., Merghoub, T., Zha, Y., Malnassy, G., Fulton, N., Park, J.H., Stock, W., Nakamura, Y., Gajewski, T.F., Liu, H., Ju, X., Kosoff, R., Ramos, K., Coder, B., Petit, R., Princiotta, M., Perry, K., Zou, J., Arina, A., Fernandez, C., Zheng, W., Beckett, M.A., Mauceri, H.J., Fu, Y.X., Weichselbaum, R.R., DeBenedette, M., Lewis, W., Gamble, A., Nicolette, C., Han, Y., Wu, Y., Yang, C., Huang, J., Wu, D., Li, J., Liang, X., Zhou, X., Hou, J., Hassan, R., Jahan, T., Antonia, S.J., Kindler, H.L., Alley, E.W., Honarmand, S., Liu, W., Leong, M.L., Whiting, C.C., Nair, N., Enstrom, A., Lemmens, E.E., Tsujikawa, T., Kumar, S., Coussens, L.M., Murphy, A.L., Brockstedt, D.G., Koch, S.D., Sebastian, M., Weiss, C., Früh, M., Pless, M., Cathomas, R., Hilbe, W., Pall, G., Wehler, T., Alt, J., Bischoff, H., Geissler, M., Griesinger, F., Kollmeier, J., Papachristofilou, A., Doener, F., Fotin-Mleczek, M., Hipp, M., Hong, H.S., Kallen, K.J., Klinkhardt, U., Stosnach, C., Scheel, B., Schroeder, A., Seibel, T., Gnad-Vogt, U., Zippelius, A., Park, H.R., Ahn, Y.O., Kim, T.M., Kim, S., Kim, S., Lee, Y.S., Keam, B., Kim, D.W., Heo, D.S., Pilon-Thomas, S., Weber, A., Morse, J., Kodumudi, K., Liu, H., Mullinax, J., Sarnaik, A.A., Pike, L., Bang, A., Ott, P.A., Balboni, T., Taylor, A., Spektor, A., Wilhite, T., Krishnan, M., Cagney, D., Alexander, B., Aizer, A., Buchbinder, E., Awad, M., Ghandi, L., Hodi, F.S., Schoenfeld, J., Schwartz, A.L., Nath, P.R., Lessey-Morillon, E., Ridnour, L., Roberts, D.D., Segal, N.H., Sharma, M., Le, D.T., Ott, P.A., Ferris, R.L., Zelenetz, A.D., Neelapu, S.S., Levy, R., Lossos, I.S., Jacobson, C., Ramchandren, R., Godwin, J., Colevas, A.D., Meier, R., Krishnan, S., Gu, X., Neely, J., Suryawanshi, S., Timmerman, J., Vanpouille-Box, C.I., Formenti, S.C., Demaria, S., Wennerberg, E., Mediero, A., Cronstein, B.N., Formenti, S.C., Demaria, S., Gustafson, M.P., DiCostanzo, A., Wheatley, C., Kim, C.H., Bornschlegl, S., Gastineau, D.A., Johnson, B.D., Dietz, A.B., MacDonald, C., Bucsek, M., Qiao, G., Hylander, B., Repasky, E., Turbitt, W.J., Xu, Y., Mastro, A., Rogers, C.J., Withers, S., Wang, Z., Khuat, L.T., Dunai, C., Blazar, B.R., Longo, D., Rebhun, R., Grossenbacher, S.K., Monjazeb, A., Murphy, W.J., Rowlinson, S., Agnello, G., Alters, S., Lowe, D., Scharping, N., Menk, A.V., Whetstone, R., Zeng, X., Delgoffe, G.M., Santos, P.M., Menk, A.V., Shi, J., Delgoffe, G.M., Butterfield, L.H., Whetstone, R., Menk, A.V., Scharping, N., Delgoffe, G., Nagasaka, M., Sukari, A., Byrne-Steele, M., Pan, W., Hou, X., Brown, B., Eisenhower, M., Han, J., Collins, N., Manguso, R., Pope, H., Shrestha, Y., Boehm, J., Haining, W.N., Cron, K.R., Sivan, A., Aquino-Michaels, K., Gajewski, T.F., Orecchioni, M., Bedognetti, D., Hendrickx, W., Fuoco, C., Spada, F., Sgarrella, F., Cesareni, G., Marincola, F., Kostarelos, K., Bianco, A., Delogu, L., Hendrickx, W., Roelands, J., Boughorbel, S., Decock, J., Presnell, S., Wang, E., Marincola, F.M., Kuppen, P., Ceccarelli, M., Rinchai, D., Chaussabel, D., Miller, L., Bedognetti, D., Nguyen, A., Sanborn, J.Z., Vaske, C., Rabizadeh, S., Niazi, K., Benz, S., Patel, S., Restifo, N., White, J., Angiuoli, S., Sausen, M., Jones, S., Sevdali, M., Simmons, J., Velculescu, V., Diaz, L., Zhang, T., Sims, J.S., Barton, S.M., Gartrell, R., Kadenhe-Chiweshe, A., Dela Cruz, F., Turk, A.T., Lu, Y., Mazzeo, C.F., Kung, A.L., Bruce, J.N., Saenger, Y.M., Yamashiro, D.J., Connolly, E.P., Baird, J., Crittenden, M., Friedman, D., Xiao, H., Leidner, R., Bell, B., Young, K., Gough, M., Bian, Z., Kidder, K., Liu, Y., Curran, E., Chen, X., Corrales, L.P., Kline, J., Dunai, C., Aguilar, E.G., Khuat, L.T., Murphy, W.J., Guerriero, J., Sotayo, A., Ponichtera, H., Pourzia, A., Schad, S., Carrasco, R., Lazo, S., Bronson, R., Letai, A., Kornbluth, R.S., Gupta, S., Termini, J., Guirado, E., Stone, G.W., Meyer, C., Helming, L., Tumang, J., Wilson, N., Hofmeister, R., Radvanyi, L., Neubert, N.J., Tillé, L., Barras, D., Soneson, C., Baumgaertner, P., Rimoldi, D., Gfeller, D., Delorenzi, M., Fuertes Marraco, S.A., Speiser, D.E., Abraham, T.S., Xiang, B., Magee, M.S., Waldman, S.A., Snook, A.E., Blogowski, W., Zuba-Surma, E., Budkowska, M., Salata, D., Dolegowska, B., Starzynska, T., Chan, L., Somanchi, S., McCulley, K., Lee, D., Buettner, N., Shi, F., Myers, P.T., Curbishley, S., Penny, S.A., Steadman, L., Millar, D., Speers, E., Ruth, N., Wong, G., Thimme, R., Adams, D., Cobbold, M., Thomas, R., Hendrickx, W., Al-Muftah, M., Decock, J., Wong, M.K., Morse, M., McDermott, D.F., Clark, J.I., Kaufman, H.L., Daniels, G.A., Hua, H., Rao, T., Dutcher, J.P., Kang, K., Saunthararajah, Y., Velcheti, V., Kumar, V., Anwar, F., Verma, A., Chheda, Z., Kohanbash, G., Sidney, J., Okada, K., Shrivastav, S., Carrera, D.A., Liu, S., Jahan, N., Mueller, S., Pollack, I.F., Carcaboso, A.M., Sette, A., Hou, Y., Okada, H., Field, J.J., Zeng, W., Shih, V.F., Law, C.L., Senter, P.D., Gardai, S.J., Okeley, N.M., Penny, S.A., Abelin, J.G., Saeed, A.Z., Malaker, S.A., Myers, P.T., Shabanowitz, J., Ward, S.T., Hunt, D.F., Cobbold, M., Profusek, P., Wood, L., Shepard, D., Grivas, P., Kapp, K., Volz, B., Oswald, D., Wittig, B., Schmidt, M., Sefrin, J.P., Hillringhaus, L., Lifke, V., Lifke, A., Skaletskaya, A., Ponte, J., Chittenden, T., Setiady, Y., Valsesia-Wittmann, S., Sivado, E., Thomas, V., El Alaoui, M., Papot, S., Dumontet, C., Dyson, M., McCafferty, J., El Alaoui, S., Verma, A., Kumar, V., Bommareddy, P.K., Kaufman, H.L., Zloza, A., Kohlhapp, F., Silk, A.W., Jhawar, S., Paneque, T., Bommareddy, P.K., Kohlhapp, F., Newman, J., Beltran, P., Zloza, A., Kaufman, H.L., Cao, F., Hong, B.X., Rodriguez-Cruz, T., Song, X.T., Gottschalk, S., Calderon, H., Illingworth, S., Brown, A., Fisher, K., Seymour, L., Champion, B., Eriksson, E., Wenthe, J., Hellström, A.C., Paul-Wetterberg, G., Loskog, A., Eriksson, E., Milenova, I., Wenthe, J., Ståhle, M., Jarblad-Leja, J., Ullenhag, G., Dimberg, A., Moreno, R., Alemany, R., Loskog, A., Eriksson, E., Milenova, I., Moreno, R., Alemany, R., Loskog, A., Jhawar, S., Goyal, S., Bommareddy, P.K., Paneque, T., Kaufman, H.L., Zloza, A., Kaufman, H.L., Silk, A., Mehnert, J., Gabrail, N., Bryan, J., Medina, D., Bommareddy, P.K., Shafren, D., Grose, M., Zloza, A., Mitchell, L., Yagiz, K., Lopez, F., Mendoza, D., Munday, A., Gruber, H., Jolly, D., Fuhrmann, S., Radoja, S., Tan, W., Pourchet, A., Frey, A., Mohr, I., Mulvey, M., Ranki, T., Pesonen, S., Capasso, C., Ylösmäki, E., Cerullo, V., Andtbacka, R.H.I., Ross, M., Agarwala, S., Grossmann, K., Taylor, M., Vetto, J., Neves, R., Daud, A., Khong, H., Meek, S.M., Ungerleider, R., Welden, S., Tanaka, M., Williams, M., Andtbacka, R.H.I., Curti, B., Hallmeyer, S., Fox, B., Feng, Z., Paustian, C., Bifulco, C., Grose, M., Shafren, D., Zafar, S., Parviainen, S., Siurala, M., Hemminki, O., Havunen, R., Tähtinen, S., Bramante, S., Vassilev, L., Wang, H., Lieber, A., Hemmi, S., de Gruijl, T., Kanerva, A., Hemminki, A., Ansari, T., Sundararaman, S., Roen, D., Lehmann, P., Bloom, A.C., Bender, L.H., Walters, I.B., Terabe, M., Berzofsky, J.A., Chapelin, F., Okada, H., Ahrens, E.T., DeFalco, J., Harbell, M., Manning-Bog, A., Scholz, A., Zhang, D., Baia, G., Tan, Y.C., Sokolove, J., Kim, D., Williamson, K., Chen, X., Colrain, J., Santo, G.E., Nguyen, N., Volkmuth, W., Greenberg, N., Robinson, W., Emerling, D., Drake, C.G., Petrylak, D.P., Antonarakis, E.S., Kibel, A.S., Chang, N.N., Vu, T., Campogan, D., Haynes, H., Trager, J.B., Sheikh, N.A., Quinn, D.I., Kirk, P., Addepalli, M., Chang, T., Zhang, P., Konakova, M., Hagihara, K., Pai, S., VanderVeen, L., Obalapur, P., Kuo, P., Quach, P., Fong, L., Charych, D.H., Zalevsky, J., Langowski, J.L., Addepalli, M., Kirksey, Y., Nutakki, R., Kolarkar, S., Pena, R., Hoch, U., Zalevsky, J., Doberstein, S.K., Charych, D.H., Cha, J., Mallon, Z., Perez, M., McDaniel, A., Anand, S., Uecker, D., Nuccitelli, R., McDaniel, A., Anand, S., Cha, J., Uecker, D., Nuccitelli, R., Obermajer, N., Urban, J., Wieckowski, E., Muthuswamy, R., Ravindranathan, R., Bartlett, D., Kalinski, P., Renrick, A.N., Thounaojam, M., Thomas, P., Pellom, S., Shanker, A., Pellom, S., Thounaojam, M., Dudimah, D., Brooks, A., Sayers, T.J., Shanker, A., Su, Y.L., Adamus, T., Zhang, Q., Nechaev, S., Kortylewski, M., Wei, S., Allison, J., Anderson, C., Tang, C., Schoenhals, J., Tsouko, E., Heymach, J., de Groot, P., Chang, J., Hess, K.R., Diab, A., Sharma, P., Allison, J., Naing, A., Hong, D., Welsh, J., Albershardt, T.C., Parsons, A.J., Leleux, J., Reeves, R.S., ter Meulen, J., Berglund, P., Ascarateil, S., Koziol, M.E., Penny, S.A., Malaker, S.A., Steadman, L., Myers, P.T., Bai, D., Shabanowitz, J., Hunt, D.F., Cobbold, M., Dai, P., Wang, W., Yang, N., Shuman, S., Merghoub, T., Wolchok, J.D., Deng, L., Dillon, P., Petroni, G., Brenin, D., Bullock, K., Olson, W., Smolkin, M.E., Smith, K., Nail, C., Slingluff, C.L., Sharma, M., Fa’ak, F., Janssen, L., Khong, H., Xiao, Z., Hailemichael, Y., Singh, M., Vianden, C., Diab, A., Zalevsky, J., Hoch, U., Overwijk, W.W., Facciabene, A., Stefano, P., Chongyung, F., Rafail, S., Hailemichael, Y., Nielsen, M., Fa’ak, F., Vanderslice, P., Woodside, D.G., Market, R.V., Biediger, R.J., Marathi, U.K., Overwijk, W.W., Hollevoet, K., Geukens, N., Declerck, P., Joly, N., McIntosh, L., Paramithiotis, E., Rizell, M., Sternby, M., Andersson, B., Karlsson-Parra, A., Kuai, R., Ochyl, L., Schwendeman, A., Moon, J., Deng, W., Hudson, T.E., Lemmens, E.E., Hanson, B., Rae, C.S., Burrill, J., Skoble, J., Katibah, G., Murphy, A.L., deVries, M., Brockstedt, D.G., Leong, M.L., Lauer, P., Dubensky, T.W., Whiting, C.C., Chen, X., Hu, Y., Xia, Y., Zhou, L., Bao, Y., Huang, S., Ren, X., Hurt, E., Hollingsworth, R.E., Chang, A.E., Wicha, M.S., Li, Q., Aggarwal, C., Mangrolia, D., Cohen, R., Weinstein, G., Morrow, M., Bauml, J., Kraynyak, K., Boyer, J., Yan, J., Lee, J., Humeau, L., Oyola, S., Duff, S., Weiner, D., Yang, Z., Bagarazzi, M., McNeel, D.G., Eickhoff, J., Jeraj, R., Staab, M.J., Straus, J., Rekoske, B., Liu, G., Melssen, M., Petroni, G., Grosh, W., Varhegyi, N., Bullock, K., Smolkin, M.E., Smith, K., Galeassi, N., Deacon, D.H., Gaughan, E., Slingluff, C.L., Ghisoli, M., Barve, M., Mennel, R., Wallraven, G., Manning, L., Senzer, N., Nemunaitis, J., Ogasawara, M., Ota, S., Peace, K.M., Hale, D.F., Vreeland, T.J., Jackson, D.O., Berry, J.S., Trappey, A.F., Herbert, G.S., Clifton, G.T., Hardin, M.O., Toms, A., Qiao, N., Litton, J., Peoples, G.E., Mittendorf, E.A., Ghamsari, L., Flano, E., Jacques, J., Liu, B., Havel, J., Makarov, V., Merghoub, T., Wolchok, J.D., Hellmann, M.D., Chan, T.A., Flechtner, J.B., Stefano, P., Facciabene, A., Facciponte, J., Ugel, S., De Sanctis, F., Coukos, G., Paris, S., Pottier, A., Levy, L., Lu, B., Cappuccini, F., Pollock, E., Bryant, R., Hamdy, F., Hill, A., Redchenko, I., Sultan, H., Kumai, T., Fesenkova, V., Celis, E., Tsang, K., Fantini, M., Fernando, I., Palena, C., David, J.M., Hodge, J., Gabitzsch, E., Jones, F., Gulley, J.L., Schlom, J., Herranz, M.U., Rafail, S., Ugel, S., Facciponte, J., Stefano, P., Facciabene, A., Wada, H., Shimizu, A., Osada, T., Fukaya, S., Sasaki, E., Abolhalaj, M., Askmyr, D., Lundberg, K., Albrekt, A.S., Greiff, L., Lindstedt, M., Flies, D.B., Higuchi, T., Ornatowski, W., Harris, J., Adams, S.F., Aguilera, T., Rafat, M., Castellini, L., Shehade, H., Kariolis, M., Jang, D., vonEbyen, R., Graves, E., Ellies, L., Rankin, E., Koong, A., Giaccia, A., Ajina, R., Wang, S., Smith, J., Pierobon, M., Jablonski, S., Petricoin, E., Weiner, L.M., Sherry, L., Waller, J., Anderson, M., Bigley, A., Bernatchez, C., Haymaker, C., Tannir, N.M., Kluger, H., Tetzlaff, M., Jackson, N., Gergel, I., Tagliaferri, M., Zalevsky, J., Hoch, U., Hwu, P., Snzol, M., Hurwitz, M., Diab, A., Barberi, T., Martin, A., Suresh, R., Barakat, D., Harris-Bookman, S., Drake, C., Friedman, A., Berkey, S., Downs-Canner, S., Delgoffe, G.M., Edwards, R.P., Curiel, T., Odunsi, K., Bartlett, D., Obermajer, N., Bruno, T.C., Moore, B., Squalls, O., Ebner, P., Waugh, K., Mitchell, J., Franklin, W., Merrick, D., McCarter, M., Palmer, B., Kern, J., Vignali, D., Slansky, J., Chan, A.S.H., Qiu, X., Fraser, K., Jonas, A., Ottoson, N., Gordon, K., Kangas, T.O., Leonardo, S., Ertelt, K., Walsh, R., Uhlik, M., Graff, J., Bose, N., Gupta, R., Mandloi, N., Paul, K., Patil, A., Sathian, R., Mohan, A., Manoharan, M., Chaudhuri, A., Chen, Y., Lin, J., Ye, Y.B., Xu, C.W., Chen, G., Guo, Z.Q., Komarov, A., Chenchik, A., Makhanov, M., Frangou, C., Zheng, Y., Coltharp, C., Unfricht, D., Dilworth, R., Fridman, L., Liu, L., Rajopadhye, M., Miller, P., Concha-Benavente, F., Bauman, J., Trivedi, S., Srivastava, R., Ohr, J., Heron, D., Duvvuri, U., Kim, S., Gooding, W., Ferris, R.L., Torrey, H., Mera, T., Okubo, Y., Vanamee, E., Foster, R., Faustman, D., Gartrell, R., Stack, E., Lu, Y., Izaki, D., Beck, K., Jia, D.T., Armenta, P., White-Stern, A., Fu, Y., Blake, Z., Marks, D., Kaufman, H.L., Taback, B., Horst, B., Saenger, Y.M., Glickman, L.H., Kanne, D.B., Gauthier, K.S., Desbien, A.L., Francica, B., Katibah, G., Corrales, L.P., Leong, J.L., Sung, L., Metchette, K., Kasibhatla, S., Pferdekamper, A.M., Zheng, L., Cho, C., Feng, Y., McKenna, J.M., Tallarico, J., Bender, S., Ndubaku, C., McWhirter, S.M., Drake, C.G., Gajewski, T.F., Dubensky, T.W., Gugel, E.G., Bell, C.J.M., Munk, A., Muniz, L., Bhardwaj, N., Zhao, F., Evans, K., Xiao, C., Holtzhausen, A., Hanks, B.A., Scholler, N., Yin, C., Van der Meijs, P., Prantner, A.M., Krejsa, C.M., Smith, L., Johnson, B., Branstetter, D., Stein, P.L., Jaen, J.C., Tan, J.B., Chen, A., Chen, Y., Park, T., Powers, J.P., Sexton, H., Xu, G., Young, S.W., Schindler, U., Deng, W., Klinke, D.J., Komar, H.M., Mace, T., Serpa, G., Elnaggar, O., Conwell, D., Hart, P., Schmidt, C., Dillhoff, M., Jin, M., Ostrowski, M.C., Lesinski, G.B., Koti, M., Au, K., Peterson, N., Truesdell, P., Reid-Schachter, G., Graham, C., Craig, A., Francis, J.A., Kotlan, B., Balatoni, T., Farkas, E., Toth, L., Ujhelyi, M., Savolt, A., Doleschall, Z., Horvath, S., Eles, K., Olasz, J., Csuka, O., Kasler, M., Liszkay, G., Barnea, E., Kumar, S., Tsujikawa, T., Blakely, C., Flynn, P., Goodman, R., Bueno, R., Sugarbaker, D., Jablons, D., Broaddus, V.C., West, B., Coussens, L.M., Kunk, P.R., Obeid, J.M., Winters, K., Pramoonjago, P., Smolkin, M.E., Stelow, E.B., Bauer, T.W., Slingluff, C.L., Rahma, O.E., Lamble, A., Kosaka, Y., Huang, F., Saser, K.A., Adams, H., Tognon, C.E., Laderas, T., McWeeney, S., Loriaux, M., Tyner, J.W., Druker, B.J., Lind, E.F., Liu, Z., Lu, S., Kane, L.P., Ferris, R.L., Liu, Z., Shayan, G., Lu, S., Ferris, R.L., Femel, J., Tsujikawa, T., Lane, R., Booth, J., Lund, A.W., Melssen, M., Rodriguez, A., Slingluff, C.L., Engelhard, V.H., Metelli, A., Wu, B.X., Fugle, C.W., Saleh, R., Sun, S., Wu, J., Liu, B., Li, Z., Morris, Z.S., Guy, E.I., Heinze, C., Kler, J., Gressett, M.M., Werner, L.R., Gillies, S.D., Korman, A.J., Loibner, H., Hank, J.A., Rakhmilevich, A.L., Harari, P.M., Sondel, P.M., Newman, J., Zloza, A., Huelsmann, E., Broucek, J., Kaufman, H.L., Brech, D., Straub, T., Irmler, M., Beckers, J., Buettner, F., Schaeffeler, E., Schwab, M., Noessner, E., Anand, S., McDaniel, A., Cha, J., Uecker, D., Nuccitelli, R., Ordentlich, P., Wolfreys, A., Da Costa, A., Silva, J., Crosby, A., Staelens, L., Craggs, G., Cauvin, A., Mason, S., Paterson, A.M., Lake, A.C., Armet, C.M., O’Connor, R.W., Hill, J.A., Normant, E., Adam, A., Biniszkiewicz, D.M., Chappel, S.C., Palombella, V.J., Holland, P.M., Powers, J.P., Becker, A., Chen, A., Leleti, M.R., Newcomb, E., Sexton, H., Schindler, U., Tan, J.B.L., Young, S.W., Jaen, J.C., Rapisuwon, S., Radfar, A., Gardner, K., Gibney, G., Atkins, M., Rennier, K.R., Crowder, R., Wang, P., Pachynski, R.K., Carrero, R.M.S., Rivas, S., Beceren-Braun, F., Anthony, S., Schluns, K.S., Sawant, D., Chikina, M., Yano, H., Workman, C., Vignali, D., Salerno, E., Bedognetti, D., Mauldin, I., Deacon, D., Shea, S., Pinczewski, J., Obeid, J.M., Coukos, G., Wang, E., Gajewski, T., Marincola, F.M., Slingluff, C.L., Spranger, S., Horton, B., Gajewski, T.F., Suzuki, A., Leland, P., Joshi, B.H., Puri, R.K., Sweis, R.F., Bao, R., Luke, J., Gajewski, T.F., Theodoraki, M.N., Mogundo, F.M., Edwards, R.P., Kalinski, P., Won, H., Moreira, D., Gao, C., Zhao, X., Duttagupta, P., Jones, J., D’Apuzzo, M., Pal, S., Kortylewski, M. (2016). 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Journal for ImmunoTherapy of Cancer, 4(Suppl 1), 73.BMJ. doi: 10.1186/s40425-016-0173-6.

Han, S.J., Reis, G., Kohanbash, G., Shrivastav, S., Magill, S.T., Molinaro, A.M., McDermott, M.W., Theodosopoulos, P.V., Aghi, M.K., Berger, M.S., Butowski, N.A., Barani, I., Phillips, J.J., Perry, A., & Okada, H. (2016). Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma. J Neurooncol, 130(3), 543-552.Springer Nature. doi: 10.1007/s11060-016-2256-0.

Hodges, T.R., Ferguson, S.D., Caruso, H.G., Kohanbash, G., Zhou, S., Cloughesy, T.F., Berger, M.S., Poste, G.H., Khasraw, M., Ba, S., Jiang, T., Mikkelson, T., Yung, W.K.A., de Groot, J.F., Fine, H., Cantley, L.C., Mellinghoff, I.K., Mitchell, D.A., Okada, H., & Heimberger, A.B. (2016). Prioritization schema for immunotherapy clinical trials in glioblastoma. Oncoimmunology, 5(6), e1145332.Taylor & Francis. doi: 10.1080/2162402X.2016.1145332.

Kohanbash, G., Okada, K., Liu, S., Lin, Y., Shrivastav, S., Nicolaides, T., Mueller, S., Pollack, I., Carcaboso, A., Hou, Y., & Okada, H. (2016). HG-81NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION. Neuro-Oncology, 18(suppl_3), iii67.Oxford University Press (OUP). doi: 10.1093/neuonc/now073.77.

Lal, S., Peng, K.W., Steele, M.B., Jenks, N., Ma, H., Kohanbash, G., Phillips, J.J., & Raffel, C. (2016). Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice. Hum Gene Ther Clin Dev, 27(4), 145-151.Mary Ann Liebert. doi: 10.1089/humc.2016.062.

Müller, S., Liu, S.J., Di Lullo, E., Malatesta, M., Pollen, A.A., Nowakowski, T.J., Kohanbash, G., Aghi, M., Kriegstein, A.R., Lim, D.A., & Diaz, A. (2016). Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas. Mol Syst Biol, 12(11), 889.Springer Nature. doi: 10.15252/msb.20166969.

Najac, C., Chaumeil, M.M., Kohanbash, G., Guglielmetti, C., Gordon, J.W., Okada, H., & Ronen, S.M. (2016). Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine. Sci Rep, 6(1), 31397.Springer Nature. doi: 10.1038/srep31397.

Zhang, X., Rao, A., Sette, P., Deibert, C., Pomerantz, A., Kim, W.J., Kohanbash, G., Chang, Y., Park, Y., Engh, J., Choi, J., Chan, T., Okada, H., Lotze, M., Grandi, P., & Amankulor, N. (2016). IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. Neuro Oncol, 18(10), 1402-1412.Oxford University Press (OUP). doi: 10.1093/neuonc/now061.

Zhang, X., Rao, A., Sette, P., Deibert, C., Pomerantz, A., Kim, W.J., Kohanbash, G., Chang, Y., Park, Y., Engh, J., Choi, J., Chan, T., Okada, H., Lotze, M., Grandi, P., & Amankulor, N. (2016). IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. NEURO-ONCOLOGY, 18(10), 1402-1412. doi: 10.1093/neuonc/now061.

Ahn, B., Kohanbash, G., Ohkuri, T., Kosaka, A., Chen, X., Ikeura, M., Wang, T.C., & Okada, H. (2015). Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas. Oncoimmunology, 4(11), e1047581.Taylor & Francis. doi: 10.1080/2162402X.2015.1047581.

Castro, B., Jahangiri, A., Kuang, R., De Lay, M., Kohanbash, G., Yagnik, G., Miller, L., Shrivastav, S., Okada, H., & Aghi, M. (2015). MTR-01BEVACIZUMAB-INDUCED MIF DEPLETION: A NOVEL RESISTANCE MECHANISM IN GLIOBLASTOMA. Neuro-Oncology, 17(suppl_5), v124.Oxford University Press (OUP). doi: 10.1093/neuonc/nov219.01.

Han, S., Reis, G., Kohanbash, G., Srivastav, S., Magill, S., Molinaro, A., McDermott, M., Theodosopoulos, P., Aghi, M., Berger, M., Barani, I., Phillips, J., Perry, A., & Okada, H. (2015). IMPS-11EXPRESSION AND PROGNOSTIC IMPACT OF IMMUNE MODULATORY MOLECULE PD-L1 IN MENINGIOMA. Neuro-Oncology, 17(suppl_5), v115.Oxford University Press (OUP). doi: 10.1093/neuonc/nov217.11.

Hou, Y., Kohanbash, G., Okada, K., Shrivastav, S., Smith-Cohn, M., Nicolaides, T., Mueller, S., Carcaboso, A., Pollack, I., & Okada, H. (2015). IMPS-30NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION. Neuro-Oncology, 17(suppl_5), v119.Oxford University Press (OUP). doi: 10.1093/neuonc/nov217.29.

Kohanbash, G., Shrivastav, S., Ahn, B., Hou, Y., Costello, J., & Okada, H. (2015). IDH mutation-induced suppression of type-1 anti-glioma immune response. Journal for ImmunoTherapy of Cancer, 3(Suppl 2), p271.BMJ. doi: 10.1186/2051-1426-3-s2-p271.

Kosaka, A., Ohkuri, T., Ikeura, M., Kohanbash, G., & Okada, H. (2015). Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity. Biochem Biophys Res Commun, 458(3), 549-554.Elsevier. doi: 10.1016/j.bbrc.2015.02.003.

Liu, J., Di Lullo, E., Malatesta, M., Kohanbash, G., Castro, B., Okada, H., Kriegstein, A., Aghi, M., Lim, D., & Diaz, A. (2015). GENO-14SINGLE-CELL TRANSCIPTOMICS AND GENOMICS REVEALS A DIVERSITY OF TUMOR AND IMMUNE CELL POLARIZATION SIGNALS IN GBM. Neuro-Oncology, 17(suppl_5), v94.Oxford University Press (OUP). doi: 10.1093/neuonc/nov215.14.

Okada, H., Butterfield, L.H., Hamilton, R.L., Hoji, A., Sakaki, M., Ahn, B.J., Kohanbash, G., Drappatz, J., Engh, J., Amankulor, N., Lively, M.O., Chan, M.D., Salazar, A.M., Shaw, E.G., Potter, D.M., & Lieberman, F.S. (2015). Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Clin Cancer Res, 21(2), 286-294.American Association for Cancer Research (AACR). doi: 10.1158/1078-0432.CCR-14-1790.

Okada, H., Butterfield, L., Hamilton, R., Ahn, B., Kohanbash, G., Drappatz, J., Engh, J., Amankulor, N., Lively, M., Chan, M., Salazar, A., Shaw, E., Potter, D., & Lieberman, F. (2014). INDUCTION OF ROBUST TYPE-1 CD8⁺ T-CELL RESPONSES IN WHO GRADE II LOW-GRADE GLIOMA PATIENTS RECEIVING PEPTIDE-BASED VACCINES IN COMBINATION WITH POLY-ICLC. NEURO-ONCOLOGY, 16(suppl_5), v114.Oxford University Press (OUP). doi: 10.1093/neuonc/nou258.21.

Okada, H., Butterfield, L.H., Hamilton, R.L., Hoji, A., Sakaki, M., Ahn, B.J., Kohanbash, G., Drappatz, J., Engh, J., Amankulor, N., Lively, M.O., Chan, M.D., Salazar, A.M., Potter, D., Shaw, E.G., & Lieberman, F.S. (2014). ROBUST INDUCTION OF TYPE-1 CD8+T-CELL RESPONSES IN WHO GRADE II LOW-GRADE GLIOMA PATIENTS RECEIVING PEPTIDE-BASED VACCINES IN COMBINATION WITH POLY-ICLC. NEURO-ONCOLOGY, 16(suppl_3), iii39.Oxford University Press (OUP). doi: 10.1093/neuonc/nou208.62.

Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A.H., Amankulor, N., Fujita, M., Ohlfest, J.R., & Okada, H. (2013). GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α. Cancer Res, 73(21), 6413-6423.American Association for Cancer Research (AACR). doi: 10.1158/0008-5472.CAN-12-4124.

Liu, Y., Kosaka, A., Ikeura, M., Kohanbash, G., Fellows-Mayle, W., Snyder, L.A., & Okada, H. (2013). Premetastatic soil and prevention of breast cancer brain metastasis. Neuro Oncol, 15(7), 891-903.Oxford University Press (OUP). doi: 10.1093/neuonc/not031.

Kohanbash, G., & Okada, H. (2012). Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. Immunol Invest, 41(6-7), 658-679.Taylor & Francis. doi: 10.3109/08820139.2012.689591.

Kohanbash, G., & Okada, H. (2012). MicroRNAs and STAT interplay. Semin Cancer Biol, 22(1), 70-75.Elsevier. doi: 10.1016/j.semcancer.2011.12.010.

Kohanbash, G., Ishikawa, E., Fujita, M., Ikeura, M., McKaveney, K., Zhu, J., Sakaki, M., Sarkar, S.N., & Okada, H. (2012). Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma. Oncoimmunology, 1(4), 487-492.Taylor & Francis. doi: 10.4161/onci.19964.

Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R.L., Komohara, Y., Decker, S.A., Ohlfest, J.R., & Okada, H. (2011). COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res, 71(7), 2664-2674.American Association for Cancer Research (AACR). doi: 10.1158/0008-5472.CAN-10-3055.

Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T.E., Mintz, A.H., Engh, J.A., Bartlett, D.L., Brown, C.K., Zeh, H., Holtzman, M.P., Reinhart, T.A., Whiteside, T.L., Butterfield, L.H., Hamilton, R.L., Potter, D.M., Pollack, I.F., Salazar, A.M., & Lieberman, F.S. (2011). Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol, 29(3), 330-336.American Society of Clinical Oncology (ASCO). doi: 10.1200/JCO.2010.30.7744.

Fujita, M., Scheurer, M.E., Decker, S.A., McDonald, H.A., Kohanbash, G., Kastenhuber, E.R., Kato, H., Bondy, M.L., Ohlfest, J.R., & Okada, H. (2010). Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans. Clin Cancer Res, 16(13), 3409-3419.American Association for Cancer Research (AACR). doi: 10.1158/1078-0432.CCR-10-0644.

Okada, H., Kalinski, P., Kohanbash, G., Reinhart, T.A., Whiteside, T.L., Butterfield, L.H., Hamilton, R.L., Potter, D.M., Pollack, I.F., Salazar, A.M., & Lieberman, F.S. (2010). Induction of CD8+T Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type-1-Polarized Dendritic Cells and poly-ICLC In Patients with Recurrent Malignant Glioma. JOURNAL OF IMMUNOTHERAPY, 33(8), 917.

Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T.E., Mintz, A.H., Engh, J.A., Bartlett, D.L., Brown, C.K., Zeh, H., Holtzman, M.P., Reinhart, T.A., Whiteside, T.L., Butterfield, L.H., Hamilton, R.L., Potter, D.M., Pollack, I.F., Salazar, A.M., & Lieberman, F.S. (2010). SUCCESSFUL INDUCTION OF TYPE-1 CD8⁺ T CELL RESPONSES AND CLINICAL ACTIVITY BY GLIOMA VACCINES WITH ALPHA-TYPE-1-POLARIZED DCS AND POLY-ICLC. NEURO-ONCOLOGY, 12, 33.

Okada, H., Kohanbash, G., & Lotze, M.T. (2010). MicroRNAs in immune regulation--opportunities for cancer immunotherapy. Int J Biochem Cell Biol, 42(8), 1256-1261.Elsevier. doi: 10.1016/j.biocel.2010.02.002.

Sasaki, K., Kohanbash, G., Hoji, A., Ueda, R., McDonald, H.A., Reinhart, T.A., Martinson, J., Lotze, M.T., Marincola, F.M., Wang, E., Fujita, M., & Okada, H. (2010). miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy. J Transl Med, 8(1), 17.Springer Nature. doi: 10.1186/1479-5876-8-17.

Wettergreen, D., Moreland, S., Skonieczny, K., Jonak, D., Kohanbash, D., & Teza, J. (2010). Design and field experimentation of a prototype Lunar prospector. INTERNATIONAL JOURNAL OF ROBOTICS RESEARCH, 29(12), 1550-1564.SAGE Publications. doi: 10.1177/0278364910370217.

Zhu, X., Fallert-Junecko, B.A., Fujita, M., Ueda, R., Kohanbash, G., Kastenhuber, E.R., McDonald, H.A., Liu, Y., Kalinski, P., Reinhart, T.A., Salazar, A.M., & Okada, H. (2010). Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners. Cancer Immunol Immunother, 59(9), 1401-1409.Springer Nature. doi: 10.1007/s00262-010-0876-3.

Fujita, M., Zhu, X., Ueda, R., Sasaki, K., Kohanbash, G., Kastenhuber, E.R., McDonald, H.A., Gibson, G.A., Watkins, S.C., Muthuswamy, R., Kalinski, P., & Okada, H. (2009). Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10. Cancer Res, 69(4), 1587-1595.American Association for Cancer Research (AACR). doi: 10.1158/0008-5472.CAN-08-2915.

Okada, H., Kohanbash, G., Zhu, X., Kastenhuber, E.R., Hoji, A., Ueda, R., & Fujita, M. (2009). Immunotherapeutic approaches for glioma. Crit Rev Immunol, 29(1), 1-42.Begell House. doi: 10.1615/critrevimmunol.v29.i1.10.

Sasaki, K., Pardee, A.D., Qu, Y., Zhao, X., Ueda, R., Kohanbash, G., Bailey, L.M., Okada, H., Muthuswamy, R., Kalinski, P., Basse, P.H., Falo, L.D., & Storkus, W.J. (2009). IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors. J Immunother, 32(8), 793-802.Wolters Kluwer. doi: 10.1097/CJI.0b013e3181acec1e.

Ueda, R., Fujita, M., Zhu, X., Sasaki, K., Kastenhuber, E.R., Kohanbash, G., McDonald, H.A., Harper, J., Lonning, S., & Okada, H. (2009). Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines. Clin Cancer Res, 15(21), 6551-6559.American Association for Cancer Research (AACR). doi: 10.1158/1078-0432.CCR-09-1067.

Ueda, R., Kohanbash, G., Sasaki, K., Fujita, M., Zhu, X., Kastenhuber, E.R., McDonald, H.A., Potter, D.M., Hamilton, R.L., Lotze, M.T., Khan, S.A., Sobol, R.W., & Okada, H. (2009). Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci U S A, 106(26), 10746-10751.Proceedings of the National Academy of Sciences. doi: 10.1073/pnas.0811817106.

Okada, H., Low, K.L., Kohanbash, G., McDonald, H.A., Hamilton, R.L., & Pollack, I.F. (2008). Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas. J Neurooncol, 88(3), 245-250.Springer Nature. doi: 10.1007/s11060-008-9566-9.

Marcus, S., & Kohanbash, K. (1978). Fourier series and estimation: An application to optical phase tracking (Corresp.). IEEE Transactions on Information Theory, 24(6), 775-779.Institute of Electrical and Electronics Engineers (IEEE). doi: 10.1109/tit.1978.1055954.

Chilukuri, A., Halbert, M., Golbourn, B., Varadharajan, S., Krug, B., Mbah, N., Casillo, S., Gatesman, T., Cruz, A., Zapotocky, M., Hu, B., Kohanbash, G., Bertrand, K., Kleinman, C., Lyssiotis, C., Jabado, N., Pollack, I., Mack, S., & Agnihotri, S. (2023). H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16. In NEURO-ONCOLOGY, 25(Supplement_1), (p. i21).Oxford University Press (OUP). doi: 10.1093/neuonc/noad073.083.

Frederico, S., Vincze, S., Nisnboym, M., Li, B., Sneiderman, C., Server, R., Day, K., LaToche, J., Nedrow, J., Edwards, W., & Kohanbash, G. (2023). VISUALIZATION OF TIGIT IN THE GLIOMA MICROENVIRONMENT: THE CREATION OF A PET IMAGING TRACER. In NEURO-ONCOLOGY, 25(Supplement_1), (pp. i46-i47).Oxford University Press (OUP). doi: 10.1093/neuonc/noad073.179.

Jha, R., Xiong, Z., Sneiderman, C., O'Brien, C., Feldman, K., Vagni, V., Zusman, B., Catapano, J., Winkler, E., Mihaljevic, S., Shahjouei, S., Rani, A., Raikwar, S., Rajasundaram, D., Kochanek, P., & Kohanbash, G. (2023). SINGLE-CELL ATLAS REVEALS HETEROGENEOUS CELL COMMUNICATION IN MURINE TBI. In CRITICAL CARE MEDICINE, 51(1), (p. 263).

Jha, R., Xiong, Z., Sneiderman, C., Simon, D., Catapano, J., Rulney, J., Raikwar, S., Rani, A., Shahjouei, S., Mihaljevic, S., Winkler, E., Miller, M., Lim, L.I., Feldman, K.J., Vagni, V., Kochanek, P., Kohanbash, G., & Rajasundaram, D. (2023). Sex-based Single-Cell Heterogeneity after Murine Contusional Traumatic Brain Injury in Genes Related to Sulfonylurea Receptor-1. In NEUROLOGY, 100(17).Wolters Kluwer. doi: 10.1212/WNL.0000000000203245.

Raphael, I., Nisnboym, M., Raphael, R.A., Uttam, S., Pollack, I.F., Chikina, M., Rajasundaram, D., & Kohanbash, G. (2023). T cell receptor (TCR) landscape of childhood brain tumors. In CANCER RESEARCH, 83(7), (p. 1198).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2023-1198.

Sneiderman, C., Xiong, Z., Rajasundaram, D., Simons, D., Catapano, J., Mihaljevic, S., Shahjouei, S., Raikwar, S., Rani, A., Trivedi, R., Rulney, J., Winkler, E., Miller, M., Lim, L.I., Janesko-Feldman, K., Vagni, V.A., Kohanbash, G., Kochanek, P.M., & Jha, R. (2023). Increasing SUR1-related pathway activity with increasing injury severity in immune and neurovascular cells after murine TBI. In NEUROLOGY, 100(17).Wolters Kluwer. doi: 10.1212/WNL.0000000000202677.

Xiong, Z., Nelson, B., Sneiderman, C., Janesko-Feldman, K., Kochanek, P., Rajasundaram, D., Jha, R., Kohanbash, G., & Simon, D. (2023). Microbiota-derived SCFAs Promote Chronic Neurogenesis and Anti-inflammatory Gene Expression after Traumatic Brain Injury. In NEUROLOGY, 100(17).Wolters Kluwer. doi: 10.1212/WNL.0000000000203108.

Xiong, Z., Sneiderman, C., Rajasundaram, D., Simon, D., Catapano, J., Rulney, J., Raikwar, S., Rani, A., Shahjouei, S., Mihaljevic, S., Winkler, E., Janesko-Feldman, K., Trivedi, R., Vagni, V., Kochanek, P., Jha, R., & Kohanbash, G. (2023). Single-cell RNA analysis reveals cell-specific increases in SUR1-related pathway activity with age in murine brain. In NEUROLOGY, 100(17).Wolters Kluwer. doi: 10.1212/WNL.0000000000203097.

Ziv, M.N., Vincze, S.R., Raphael, I., Xiong, Z., Sneiderman, C.T., Raphael, R.A., Li, B., Jaswal, A.P., Sever, R., Day, K.E., LaToche, J.D., Foley, L.M., Hitchens, T.K., Agnihotri, S., Hu, B., Rajasundaram, D., Anderson, C.J., Blumenthal, D.T., Pearce, T.M., Uttam, S., Nedrow, J.R., Panigrahy, A., Pollack, I.F., Lieberman, F.S., Drappatz, J., Edwards, W.B., & Kohanbash, G. (2023). Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival following Immunotherapy in Murine GBM. In NEUROLOGY, 100(17).Wolters Kluwer. doi: 10.1212/WNL.0000000000204332.

Frederico, S., Sneiderman, C., Pollack, I., & Kohanbash, G. (2022). DEVELOPING AN ADOPTIVE CELL TRANSFER IMMUNOTHERAPY FOR PEDIATRIC HIGH-GRADE GLIOMAS. In JOURNAL FOR IMMUNOTHERAPY OF CANCER, 10, (p. A236).BMJ. doi: 10.1136/jitc-2022-SITC2022.0222.

Halbert, M., Golbourn, B., Halligan, K., Varadharajan, S., Krug, B., Mbah, N., Kabir, N., Stanton, A.C., Locke, A., Casillo, S., Zhao, Y., Sanders, L., Cheney, A., Mullett, S., Chen, A., Wassell, M., Andren, A., Perez, J., Jane, E., Premkumar, D., Koncar, R., Mirhadi, S., McCarl, L., Chang, Y.F., Wu, Y., Gatesman, T., Cruz, A., Zapotocky, M., Hu, B., Kohanbash, G., Wang, X., Vartanian, A., Moran, M., Lieberman, F., Amankulor, N., Wendell, S., Vaske, O.M., Panigraphy, A., Felker, J., Bertrand, K.C., Kleinman, C., Rich, J.N., Friedlander, R.M., Broniscer, A., Lyssiotis, C., Jabado, N., Pollack, I.F., Mack, S.C., & Agnihotri, S. (2022). LOSS OF MAT2A COMPROMISES METHIONINE METABOLISM AND REPRESENTS A VULNERABILITY IN H3K27M MUTANT GLIOMAS. In NEURO-ONCOLOGY, 24, (p. 263).

Jha, R., Xiong, Z., Sneiderman, C., O'Brien, C., Raphael, I., Feldman, K.J., Vagni, V., Bogomilsky, C., Zusman, B., Catapano, J., Winkler, E., Mihaljevic, S., Rani, A., Raikwar, S., Karahalios, K., Casabella, A.M., Rajasundaram, D., Kochanek, P., & Kohanbash, G. (2022). SINGLE-CELL ATLAS ACROSS THREE MURINE TBI MODELS YIELDS HETEROGENEOUS TRANSCRIPTOME BASED ON SEVERITY, SEX, CORTICAL REGION, AND CELL-SUBTYPE - IDENTIFYING NOVEL POTENTIAL BIOMARKERS AND TARGETS. In JOURNAL OF NEUROTRAUMA, 39(15-16), (pp. A13-A14).

Lee, J., Sneiderman, C., Kohanbash, G., Sangwan, N., & Lathia, J. (2022). SEX-SPECIFIC T CELL BEHAVIOR DRIVES DIFFERENTIAL IMMUNE RESPONSES IN GLIOBLASTOMA. In NEURO-ONCOLOGY, 24, (pp. 282-283).

Nisnboym, M., Vincze, S., Raphael, I., Sneiderman, C., Xiong, Z., Li, B., Day, K., Latoche, J., Nedrow, J., Anderson, C., Pearce, T., Pollack, I., Lieberman, F., Drappatz, J., Edwards, W., & Kohanbash, G. (2022). IMMUNOPET OF ⁸⁹ZR-DFO-CD69 AB VISUALIZES T-CELL ACTIVATION AND PREDICTS SURVIVAL FOLLOWING IMMUNOTHERAPY IN MURINE GBM MODEL. In NEURO-ONCOLOGY, 24, (p. 177).

Raphael, I., Chikina, M., Broniscer, A., Pollack, I., Rajasundaram, D., & Kohanbash, G. (2022). LANDSCAPE OF ADAPTIVE IMMUNITY OF CHILDHOOD BRAIN CANCERS. In NEURO-ONCOLOGY, 24, (p. 82).

Rinehardt, H., Longo, S., Gilbert, R., Edwards, W.B., Kohanbash, G., & Malek, M. (2022). HANDHELD PET PROBE FOR PEDIATRIC CANCER SURGERY. In PEDIATRIC BLOOD & CANCER, 69.

Zou, H., Poore, B., Brown, E., Yash, P., Hu, Z., Li, X., Pollack, I.F., Friedlander, R.M., Hainer, S., Taylor, M., & Hu, B. (2022). HIJACKING A NEURODEVELOPMENTAL EPIGENOMIC PROGRAM IN METASTATIC DISSEMINATION OF MEDULLOBLASTOMA. In NEURO-ONCOLOGY, 24, (p. 227).Research Square Platform. doi: 10.21203/rs.3.rs-1270726/v1.

Babikir, H., Wang, L., Shamardani, K., Sudhir, S., Kohanbash, G., Aghi, M., Philips, J., & Diaz, A. (2020). AN EPIGENETIC SINGLE-CELL ATLAS OF IDH-MUTANT GLIOMA REVEALS THE ROLE OF ATRX IN SHAPING TUMOR COMPOSITION. In NEURO-ONCOLOGY, 22, (p. 76).

Kotani, T., Takano, H., Yoshida, T., Hamasaki, R., Kohanbash, G., Takeda, K., & Okada, H. (2020). Inhibition of PGE2/EP4 pathway by ONO-4578/BMS-986310, a novel EP4 antagonist, promotes T cell activation and myeloid cell differentiation to dendritic cells. In CANCER RESEARCH, 80(16), (p. 4443).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2020-4443.

Nigam, S., Tatum, D., Foster, A., Plakseychuk, E., Edinger, R., Edwards, W., Kohanbash, G., Magda, D., & Anderson, C. (2020). SPECT and PET imaging of CD11b-positive immune cells in an orthotopic mouse model of glioma with Zr-89 and Lu-177 labeled Lumi804-anti-CD11b antibody. In JOURNAL OF NUCLEAR MEDICINE, 61.

Wang, L., Babikir, H., Shamardani, K., Catalan, F., Sudhir, S., Kohanbash, G., Aghi, M., Chang, S., Philips, J., & Diaz, A. (2020). A SINGLE-CELL ATLAS OF GLIOBLASTOMA EVOLUTION UNDER THERAPY. In NEURO-ONCOLOGY, 22, (pp. 72-73).

Campagna, M., Ma, X., McCarl, L., Kumar, R., Broniscer, A., Agnihotri, S., Felker, J., Pollack, I., & Kohanbash, G. (2019). PROTEASOME AND HDAC INHIBITORS ARE CYTOTOXIC AGAINST RELA-FUSION PEDIATRIC EPENDYMOMA CELLS. In NEURO-ONCOLOGY, 21(Supplement_2), (p. 79).Oxford University Press (OUP). doi: 10.1093/neuonc/noz036.068.

Foster, A., Kumar, R., Nigam, S., McCarl, L., Edinger, R., Pollack, I., Anderson, C., Edwards, W., Kohanbash, G.Foster, A. (2019). ImmunoPET imaging of glioma-infiltrating myeloid cells using Zirconium-89-labeled anti-CD11b antibody. In JOURNAL FOR IMMUNOTHERAPY OF CANCER, 7.

Hasan, M.N., Guan, X., Ahuja, A., Castro, M., Kohanbash, G., & Sun, D. (2019). H⁺ EXTRUSION PROTEIN NA/H EXCHANGER IN METABOLIC POLARIZATION OF GLIOMA-ASSOCIATED MICROGLIA/MACROPHAGES AND TUMOR IMMUNITY. In NEURO-ONCOLOGY, 21, (p. 251).

Koncar, R., Stanton, A.C., Dey, B., Agrawal, N., Wassell, M., McCarl, L., Locke, A., Sanders, L., Vaske, O.M., Kohanbash, G., Felker, J., James, C.D., Hashizume, R., Broniscer, A., Pollack, I., & Agnihotri, S. (2019). ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKS) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG. In NEURO-ONCOLOGY, 21(Supplement_2), (p. 70).Oxford University Press (OUP). doi: 10.1093/neuonc/noz036.032.

Kumar, R., McCarl, L., Foster, A., Nigam, S., Ma, X., Campagna, M., Broniscer, A., Warren, K., Pollack, I., & Kohanbash, G. (2019). DNA methyltransferase inhibition immunosensitizes diffuse intrinsic pontine gliomas to peptide vaccine through augmentation of EphA2 and MHC I expression. In JOURNAL FOR IMMUNOTHERAPY OF CANCER, 7.

Luo, L., Guan, X., Begum, G., Ding, D., Kohanbash, G., Sun, B., & Sun, D. (2019). NA-K-CL COTRANSPORTER PROTEIN IN THE PATHOGENESIS OF LOW-GRADE GLIOMAS. In NEURO-ONCOLOGY, 21, (p. 44).

McCarl, L., Kumar, R., Nigam, S., Broniscer, A., Agnihotri, S., Edwards, B., Warren, K., Pollack, I., & Kohanbash, G. (2019). GUADECITABINE (SGI-110) IMMUNOSENSTTIZES MURINE C57BL/6-SYNGENEIC GLIOMA AND DIPG MODELS. In NEURO-ONCOLOGY, 21(Supplement_2), (p. 96).Oxford University Press (OUP). doi: 10.1093/neuonc/noz036.137.

Nigam, S., McCarl, L., Anderson, C., Panigrahy, A., Pollack, I., Edwards, B., & Kohanbash, G. (2019). DEVELOPMENT OF PET TRACERS FOR NON-INVASIVE IMAGING OF IMMUNOTHERAPY IN DIFFUSE INTRINSIC PONTINF GLIOMA. In NEURO-ONCOLOGY, 21(Supplement_2), (p. 97).Oxford University Press (OUP). doi: 10.1093/neuonc/noz036.140.

Nigam, S., McCarl, L., Edinger, R.S., Kumar, R., Anderson, C., Kohanbash, G., & Edwards, W.B. (2019). Development of MDSC-CD1113 tracer for immune PET imaging in glioblastoma model. In JOURNAL OF NUCLEAR MEDICINE, 60.

Nigam, S., McCarl, L., Kumar, R., Anderson, C., Edwards, B., & Kohanbash, G. (2019). DEVELOPMENT OF CD11b TRACER FOR THE IMMUNE PET IMAGING IN GLIOBLASTOMA MODEL - COULD BE A GAME CHANGER FOR IMMUNOTHERAPY APPROACHES. In NEURO-ONCOLOGY, 21, (p. 256).

Chen, A., Sharma, V., Wang, Q., Agnihotri, S., Kohanbash, G., Wang, Y.A., Pollack, I., DePinho, R., & Hu, B. (2018). AUTO-/PARACRINE SIGNALING OF PI3K/AKT/YKL-40 IN MESENCHYMAL GLIOBLASTOMA PROGRESSION. In NEURO-ONCOLOGY, 20, (pp. 258-259).

Hasan, N., Guan, X., Kohanbash, G., & Sun, D. (2018). Na/H EXCHANGER ISOFORM 1 (NHE1) IN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT IN MOUSE SYNGENEIC GLIOMA MODEL. In NEURO-ONCOLOGY, 20, (p. 263).

Kohanbash, G., McCarl, L., Shoger, K., Broniscer, A., Warren, K.E., & Pollack, I. (2018). GUADECITABINE (SGI-110) ENHANCES MHC class I AND TUMOR ANTIGEN EXPRESSION ON MURINE C57BL/6-SYNGENEIC GLIOMA AND DIPG MODELS. In NEURO-ONCOLOGY, 20, (p. 124).

Mueller, S., Agnihotri, S., Shoger, K., Myers, M., Villanueva, C., Diaz, A., Okada, H., Pollack, I., & Kohanbash, G. (2018). PEPTIDE VACCINE IMMUNOTHERAPY BIOMARKERS AND RESPONSE PATTERNS IN PEDIATRIC GLIOMAS. In NEURO-ONCOLOGY, 20, (pp. 124-125).

Shoger, K., McCarl, L., Gilbert, R., Villanueva, C., Levy, N., Amankulor, N., Pollack, I., & Kohanbash, G. (2018). TARGETING THE PD1 AND TIGIT CHECKPOINT PATHWAYS FOR ADULT AND PEDIATRIC GLIOMAS. In NEURO-ONCOLOGY, 20, (p. 125).

Carrera, D., Hayes, J., Mueller, S., Shelton, S., Weinschenk, T., Song, C., Fritsche, J., Schoor, O., Kuttruff-Coqui, S., Hilf, N., Kohanbash, G., Watchmaker, P., Oldham, M., Costello, J., Singh, H., & Okada, H. (2017). SELECTION OF GLIOMA T-CELL THERAPY TARGETS BASED ON THE ANALYSIS OF TUMOR IMMUNOPEPTIDOME AND EXPRESSION PROFILES. In NEURO-ONCOLOGY, 19, (p. 124).

Chheda, Z., Kohanbash, G., Okada, K., Jahan, N., Sidney, J., Pecoraro, M., Carrera, D., Shrivastav, S., Liu, S., Downey, K., Chuntova, P., Watchmaker, P., Mueller, S., Pollack, I., Rajalingam, R., Montero Carcaboso, A., Mann, M., Sette, A., Hou, Y., & Okada, H. (2017). H3.3K27M MUTATION-DERIVED NOVEL NEOANTIGEN - CHARACTERIZATION OF THE HLA-A2-BINDING EPITOPE AND A SPECIFIC T CELL RECEPTOR FOR DEVELOPMENT OF T CELL-BASED IMMUNOTHERAPY. In NEURO-ONCOLOGY, 19, (p. 121).

Chheda, Z., Kohanbash, G., Okada, K., Jahan, N., Sidney, J., Pecoraro, M., Carrera, D., Shrivastav, S., Liu, S., Mueller, S., Pollack, I., Rajalingam, R., Carcaboso, A., Mann, M., Sette, A., Hou, Y., & Okada, H. (2017). H3.3K27M mutation-derived novel neoantigen - characterization of the HLA-A2-binding epitope and a specific T cell receptor for development of T cell-based immunotherapy. In JOURNAL FOR IMMUNOTHERAPY OF CANCER, 5.

Chheda, Z., Kohanbash, G., Sidney, J., Okada, K., Jahan, N., Mueller, S., Sette, A., Hou, Y., & Okada, H. (2017). IDENTIFICATION OF A NOVEL H3.3.K27M MUTATION-DERIVED NEOANTIGEN EPITOPE AND CLONING OF H3.3.K27M-SPECIFIC T-CELL RECEPTOR FOR T-CELL THERAPY IN GLIOMAS. In NEURO-ONCOLOGY, 19, (pp. 18-19).

Kohanbash, G., Kotani, T., Chuntova, P., Shoger, K., Jahan, N., Shrivastav, S., Carrera, D., Downey, K., Castro, B., Takeda, K., & Okada, H. (2017). ONO-AE3-208 PROMOTES ANTI-TUMOR IMMUNE ACTIVITY AND SURVIVAL IN GLIOMA MODELS. In NEURO-ONCOLOGY, 19, (p. 122).

Mueller, S., Kohanbash, G., Liu, S., Carrera, D., Watchmaker, P., Jahan, N., Alvarado, B., Lim, D., Aghi, M., Okada, H., & Diaz, A. (2017). TUMOR GENETICS AND MACROPHAGE ONTOGENY SHAPE THE INNATE IMMUNE RESPONSE TO GLIOMA. In NEURO-ONCOLOGY, 19, (p. 245).

Hou, Y., Kohanbash, G., Okada, K., Shrivastav, S., Smith-Cohn, M., Nicolaides, T., Mueller, S., Carcaboso, A.M., Pollack, I.F., & Okada, H. (2016). Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation. In CANCER IMMUNOLOGY RESEARCH, 4(1), (p. a117).American Association for Cancer Research (AACR). doi: 10.1158/2326-6074.CRICIMTEATIAACR15-A117.

Kohanbash, G., Chheda, Z., Sidney, J., Okada, K., Shrivastav, S., Carrera, D., Liu, S., Jahan, N., Mueller, S., Pollack, I., Carcaboso, A., Sette, A., Hou, Y., & Okada, H. (2016). IDENTIFICATION OF A NOVEL H3.3.K27M MUTATION-DERIVED NEOANTIGEN EPITOPE AND CLONING OF A SPECIFIC T-CELL RECEPTOR FOR T-CELL THERAPY IN GLIOMAS. In NEURO-ONCOLOGY, 18, (p. 87).

Kohanbash, G., Okada, K., Liu, S., Lin, Y., Shrivastav, S., Nicolaides, T., Mueller, S., Pollack, I., Carcaboso, A., Hou, Y., & Okada, H. (2016). NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION. In NEURO-ONCOLOGY, 18(Suppl 2), (p. 67).BMJ. doi: 10.1186/2051-1426-3-s2-p445.

Kohanbash, G., Shrivastav, S., Ahn, B., Carrera, D., Jahan, N., Beppler, C., Amankulor, N., Costello, J.F., & Okada, H. (2016). IDH1 R132H MUTATION INHIBITS ANTI-GLIOMA IMMUNE RESPONSES THROUGH POST-TRANSCRIPTIONAL DOWN-REGULATION OF STAT1 AND TYPE-1 CHEMOKINES. In NEURO-ONCOLOGY, 18, (p. 88).

Muller, S., Kohanbash, G., Liu, S., Carrera, D., Aghi, M., Lim, D., Okada, H., & Diaz, A. (2016). DISTINCT MOLECULAR SIGNATURES OF MICROGLIA AND BONE-MARROW MACROPHAGES IN THE GLIOMA PERIVASCULAR NICHE. In NEURO-ONCOLOGY, 18, (p. 206).

Muller, S., Liu, S., Malatesta, M., Aghi, M., Kriegstein, A., Kohanbash, G., Lim, D., & Diaz, A. (2016). SINGLE-CELL PROFILING OF GLIOBLASTOMA BIOPSIES IDENTIFIES A FAMILY OF ACTIVATING PDGF-RECEPTOR DELETIONS. In NEURO-ONCOLOGY, 18, (p. 78).

Najac, C., Chaumeil, M.M., Kohanbash, G., Guglielmetti, C., Gordon, J., Okada, H., & Ronen, S.M. (2016). IMAGING INFLAMMATORY CELL FUNCTION USING 13C MAGNETIC RESONANCE SPECTROSCOPY OF HYPERPOLARIZED 6-13C-LABELED ARGININE. In NEURO-ONCOLOGY, 18, (p. 86).

Ahn, B., Kohanbash, G., Kosaka, A., Ohkuri, T., & Okada, H. (2014). Histamine in myeloid cell maturation and malignant glioma development. In CANCER RESEARCH, 74(19), (p. 4846).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2014-4846.

Gary, K., Straw, E., Averick, A., Ahn, B., Smith-Cohn, M., Ohkuri, T., Kosaka, A., & Okada, H. (2014). ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth. In CANCER RESEARCH, 74(19), (p. lb-265-lb-265).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2014-LB-265.

Kohanbash, G., Straw, E., Averick, A., Ahn, B., Smith-Cohn, M., Ohkuri, T., Kosaka, A., & Okada, H. (2014). ONO-AE3-208 INHIBITS MYELOID-DERIVED SUPPRESSOR CELLS AND GLIOMA GROWTH. In NEURO-ONCOLOGY, 16(suppl_5), (p. v113).Oxford University Press (OUP). doi: 10.1093/neuonc/nou258.15.

Smith-Cohn, M., Kohanbash, G., Muthuswamy, R., Ohkuri, T., Kosaka, A., Amankulor, N., Engh, J., Potter, D., Kalinski, P., & Okada, H. (2014). USE OF IFN-ALPHA AND POLY-ICLC AS CHEMOKINE MODULATORS FOR IMMUNOTHERAPY IN GLIOMAS. In NEURO-ONCOLOGY, 16(suppl_5), (p. v117).Oxford University Press (OUP). doi: 10.1093/neuonc/nou258.31.

Zhang, X., Chang, Y., Brancho, M., Kohanbash, G., Leo, M., Okada, H., Lotze, M., & Amankulor, N. (2014). Isocitrate dehydrogenase mutant glial cell resist natural killer cell cytotoxicity. In JOURNAL OF IMMUNOLOGY, 192.

Kohanbash, G., Ishikawa, E., Fujita, M., Mckaveney, K., Sakaki, M., Scheurer, M., Bondy, M., Sarkar, S.N., & Okada, H. (2012). ELK-1 regulates interferon-alpha8 expression via a polymorphic region in the interferon-alpha8 promoter associated with outcome of glioma patients. In CANCER RESEARCH, 72(8_Supplement), (p. 1246).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2012-1246.

Kohanbash, G., McKaveney, K., Sakaki, M., Fujita, M., & Okada, H. (2012). GM-CSF-induced IL-4Rα Expression on Glioma-infiltrating Monocytes Promotes Immunosuppression and Glioma Growth. In JOURNAL OF IMMUNOTHERAPY, 35(9), (p. 777).

Fujita, M., Kohanash, G., Fellows-Mayle, W., Hamilton, R.L., Decker, S.A., Ohlfest, J.R., & Okada, H. (2011). COX-2 blockade suppresses gliomagenesis by inhibiting CCL2-mediated accumulation of myeloid-derived suppressor cells. In CANCER RESEARCH, 71(8_Supplement), (p. 1788).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.AM2011-1788.

Kohanbash, G., Ishikawa, E., Fujita, M., Ohno, M., Liu, Y., Sakaki, M., Ikeura, M., Scheurer, M., Bondy, M., & Okada, H. (2011). ELK-1 REGULATES INTERFERON-ALPHA-8 EXPRESSION VIA A POLYMORPHIC REGION IN INTERFERON-ALPHA-8 PROMOTER ASSOCIATED WITH THE PROGNOSIS OF GLIOMA PATIENTS. In NEURO-ONCOLOGY, 13, (p. 32).

Kohanbash, G., McKaveney, K., Sakaki, M., Mintz, A., Ohlfest, J., Bondy, M., Fujita, M., & Okada, H. (2011). INTERLEUKIN-4 RECEPTOR ALPHA CHAIN (IL-4R-ALPHA) PROMOTES THE IMMUNOSUPPRESSIVE ACTIVITY OF GLIOMA-INFILTRATING MONOCYTES. In NEURO-ONCOLOGY, 13, (p. 31).

Valada, A., Kohanbash, D., & Kantor, G. (2011). Dsrp: distributed sensorweb routing protocol. In CONIELECOMP 2011, 21st International Conference on Electrical Communications and Computers, (pp. 310-315).Institute of Electrical and Electronics Engineers (IEEE). doi: 10.1109/conielecomp.2011.5749328.

Fujita, M., Decker, S.A., Popescu, F., McDonald, H.A., Kohanbash, G., Ohlfest, J.R., & Okada, H. (2010). Abstract 1359: COX2 blockade suppresses glioma-genesis by promoting anti-glioma immunosurveillance. In Cancer Research, 70(8_Supplement), (p. 1359).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.am10-1359.

Fujita, M., Kohanbash, G., McDonald, H.A., Delamarre, L., Decker, S.A., Ohlfest, J.R., & Okada, H. (2010). COX2 BLOCKADE SUPPRESSES GLIOMAGENESIS BY INHIBITING CCL2-MEDIATED ACCUMULATION OF MYELOID-DERIVED SUPPRESSOR CELLS IN GLIOMA SITES. In NEURO-ONCOLOGY, 12, (p. 32).

Fujita, M., Kohanbash, G., McDonald, H.A., Delamarre, L., Decker, S.A., Ohlfest, J.R., & Okada, H. (2010). COX2 Blockade Suppresses Gliomagenesis by Inhibiting CCL2-Mediated Accumulation of Myeloid-derived Suppressor Cells in Glioma Sites. In JOURNAL OF IMMUNOTHERAPY, 33(8), (p. 897).

Kohanbash, G., Mintz, A.H., McKaveney, K., McDonald, H.A., Ohlfest, J.R., Okada, H., & Fujita, M. (2010). Roles of Interleukin-4 Receptor α-chain on Glioma-Infiltrating Monocytes. In JOURNAL OF IMMUNOTHERAPY, 33(8), (p. 887).

Kohanbash, G., Mintz, A.H., McKaveney, K., McDonald, H.A., Ohlfest, J.R., Okada, H., & Fujita, M. (2010). ROLES OF INTERLEUKIN-4 RECEPTOR A-CHAIN ON GLIOMA-INFILTRATING MONOCYTES. In NEURO-ONCOLOGY, 12, (pp. 30-31).

Kohanbash, G., Sasaki, K., Hoji, A., Fujita, M., & Okada, H. (2010). Abstract 4786: MiR-17-92 expression in differentiated T cells - Implications for cancer immunotherapy. In Cancer Research, 70(8_Supplement), (p. 4786).American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.am10-4786.

Fujita, M., Scheurer, M.E., Decker, S.A., Popescu, F., McDonald, H.A., Kohanbash, G., Kato, H., Bondy, M.L., Ohlfest, J.R., & Okada, H. (2009). A PIVOTAL ROLE OF TYPE-1 INTERFERON SIGNALING IN IMMUNOSURVEILLANCE AGAINST GLIOMA: MOUSE STUDIES LEADING TO DISCOVERY OF NOVEL PROGNOSTIC MARKERS IN HUMANS. In NEURO-ONCOLOGY, 11(5), (p. 617).

Okada, H., Ueda, R., Kohanbash, G., Sasaki, K., Fujita, M., Zhu, X., Lotze, M.T., Sobol, R.W., & Khan, S.A. (2009). DICER-REGULATED MICRORNAS 222 AND 339 PROMOTE IMMUNE ESCAPE OF CANCER CELLS THROUGH DOWNREGULATION OF ICAM-1. In NEURO-ONCOLOGY, 11(2), (p. 225).

Ueda, R., Fujita, M., Zhu, X., Sasaki, K., Kastenhuber, E.R., Kohanbash, G., McDonald, H.A., Harper, J., Lonning, S., & Okada, H. (2009). SYSTEMIC INHIBITION OF TRANSFORMING GROWTH FACTOR-2 IN GLIOMA-BEARING MICE IMPROVES THE THERAPEUTIC EFFICACY OF GLIOMA-ASSOCIATED ANTIGEN PEPTIDE VACCINES. In NEURO-ONCOLOGY, 11(5), (p. 617).

Ueda, R., Fujita, M., Zhu, X., Sasaki, K., Kastenhuber, E.R., Kohanbash, G., McDonald, H.A., Harper, J., Lonning, S., & Okada, H. (2009). SYSTEMIC INHIBITION OF TRANSFORMING GROWTH FACTOR B IN GLIOMA-BEARING MICE IMPROVED THE THERAPEUTIC EFFICACY OF PEPTIDE VACCINATIONS TARGETING GLIOMA-ASSOCIATED ANTIGENS. In NEURO-ONCOLOGY, 11(6), (p. 882).

Ueda, R., Kohanbash, G., Sasaki, K., Fujita, M., Zhu, X., Kastenhuber, E.R., McDonald, H.A., Potter, D.M., Lotze, M.T., Khan, S.A., Sobol, R.W., & Okada, H. (2009). DICER-REGULATED MICRORNAS 222 AND 339 PROMOTE RESISTANCE OF CANCER CELLS TO CYTOTOXIC T-LYMPHOCYTES BY DOWNREGULATING ICAM-1 EXPRESSION. In NEURO-ONCOLOGY, 11(6), (p. 962).

Ueda, R., Kohanbash, G., Sasaki, K., Fujita, M., Zhu, X., Lotze, M., Sobol, R., Khan, S., & Okada, H. (2008). ADDRESSING THE ANGIOGENIC SWITCH BY STUDYING TUMOR-HOST INTERACTIONS IN AN ANIMAL MODEL OF GLIOBLASTOMA MULTIFORME. In NEURO-ONCOLOGY, 10(5), (p. 807).

Ueda, R., Kohanbash, G., Sasaki, K., Fujita, M., Zhu, X., Lotze, M., Sobol, R., Khan, S., & Okada, H. (2008). DICER-REGULATED MICRORNAS 222 AND 339 PROMOTE IMMUNE-ESCAPE OF GLIOMA CELLS THROUGH DOWN REGULATION OF ICAM-1. In NEURO-ONCOLOGY, 10(5), (p. 807).

Marcus, S.I., & Kohanbash, K. (1977). Fourier series and estimation: An application to optical phase tracking. In 1977 IEEE Conference on Decision and Control including the 16th Symposium on Adaptive Processes and A Special Symposium on Fuzzy Set Theory and Applications, (pp. 215-219).Institute of Electrical and Electronics Engineers (IEEE). doi: 10.1109/cdc.1977.271574.